<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName A++V2.4.dtd?>
<?SourceDTD.Version 2.4?>
<?ConverterInfo.XSLTName springer2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Mob DNA</journal-id>
    <journal-id journal-id-type="iso-abbrev">Mob DNA</journal-id>
    <journal-title-group>
      <journal-title>Mobile DNA</journal-title>
    </journal-title-group>
    <issn pub-type="epub">1759-8753</issn>
    <publisher>
      <publisher-name>BioMed Central</publisher-name>
      <publisher-loc>London</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">10832116</article-id>
    <article-id pub-id-type="publisher-id">313</article-id>
    <article-id pub-id-type="doi">10.1186/s13100-024-00313-0</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Software</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>CRISPR-TE: a web-based tool to generate single guide RNAs targeting transposable elements</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Guo</surname>
          <given-names>Yixin</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Xue</surname>
          <given-names>Ziwei</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Gong</surname>
          <given-names>Meiting</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Jin</surname>
          <given-names>Siqian</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Wu</surname>
          <given-names>Xindi</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Liu</surname>
          <given-names>Wanlu</given-names>
        </name>
        <address>
          <email>wanluliu@intl.zju.edu.cn</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.13402.34</institution-id><institution-id institution-id-type="ISNI">0000 0004 1759 700X</institution-id><institution>Department of Orthopedic Surgery of the Second Affiliated Hospital, and Centre of Biomedical Systems and Informatics of Zhejiang University-University of Edinburgh Institute (ZJU-UoE Institute), Zhejiang University School of Medicine, </institution><institution>Zhejiang University, </institution></institution-wrap>Zhejiang, Hangzhou 310003 China </aff>
      <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00a2xv884</institution-id><institution-id institution-id-type="GRID">grid.13402.34</institution-id><institution-id institution-id-type="ISNI">0000 0004 1759 700X</institution-id><institution>Future Health Laboratory, Innovation Center of Yangtze River Delta, </institution><institution>Zhejiang University, </institution></institution-wrap>Jiaxing, 314100 China </aff>
    </contrib-group>
    <pub-date pub-type="epub">
      <day>1</day>
      <month>2</month>
      <year>2024</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>1</day>
      <month>2</month>
      <year>2024</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2024</year>
    </pub-date>
    <volume>15</volume>
    <elocation-id>3</elocation-id>
    <history>
      <date date-type="received">
        <day>29</day>
        <month>6</month>
        <year>2023</year>
      </date>
      <date date-type="accepted">
        <day>13</day>
        <month>1</month>
        <year>2024</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2024</copyright-statement>
      <license>
        <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p>
      </license>
    </permissions>
    <abstract id="Abs1">
      <sec>
        <title>Background</title>
        <p id="Par1">The CRISPR/Cas systems have emerged as powerful tools in genome engineering. Recent studies highlighting the crucial role of transposable elements (TEs) have stimulated research interest in manipulating these elements to understand their functions. However, designing single guide RNAs (sgRNAs) that are specific and efficient for TE manipulation is a significant challenge, given their sequence repetitiveness and high copy numbers. While various sgRNA design tools have been developed for gene editing, an optimized sgRNA designer for TE manipulation has yet to be established.</p>
      </sec>
      <sec>
        <title>Results</title>
        <p id="Par2">We present CRISPR-TE, a web-based application featuring an accessible graphical user interface, available at <ext-link ext-link-type="uri" xlink:href="https://www.crisprte.cn/">https://www.crisprte.cn/</ext-link>, and currently tailored to the human and mouse genomes. CRISPR-TE identifies all potential sgRNAs for TEs and provides a comprehensive solution for efficient TE targeting at both the single copy and subfamily levels. Our analysis shows that sgRNAs targeting TEs can more effectively target evolutionarily young TEs with conserved sequences at the subfamily level.</p>
      </sec>
      <sec>
        <title>Conclusions</title>
        <p id="Par3">CRISPR-TE offers a versatile framework for designing sgRNAs for TE targeting. CRISPR-TE is publicly accessible at <ext-link ext-link-type="uri" xlink:href="https://www.crisprte.cn/">https://www.crisprte.cn/</ext-link> as an online web service and the source code of CRISPR-TE is available at <ext-link ext-link-type="uri" xlink:href="https://github.com/WanluLiuLab/CRISPRTE/">https://github.com/WanluLiuLab/CRISPRTE/</ext-link>.</p>
      </sec>
      <sec>
        <title>Supplementary Information</title>
        <p>The online version contains supplementary material available at 10.1186/s13100-024-00313-0.</p>
      </sec>
    </abstract>
    <custom-meta-group>
      <custom-meta>
        <meta-name>issue-copyright-statement</meta-name>
        <meta-value>© BioMed Central Ltd., part of Springer Nature 2024</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="Sec1">
    <title>Introduction</title>
    <p id="Par4">Since the initial discovery of the CRISPR/Cas9 system for genome editing [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>], the development of catalytically inactive Cas9 variants has further facilitated its application in targeted gene expression activation [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>], repression [<xref ref-type="bibr" rid="CR3">3</xref>], and base editing [<xref ref-type="bibr" rid="CR5">5</xref>]. Transposable elements (TEs) are mobile DNA sequences capable of moving within the genome [<xref ref-type="bibr" rid="CR6">6</xref>]. Though once deemed “genomic dark matter”, recent studies have suggested that TEs may act as cis-regulatory elements, contributing to gene regulation by serving as promoters, enhancers, silencers, and boundary elements [<xref ref-type="bibr" rid="CR7">7</xref>]. For instance, in mouse early embryogenesis, the endogenous retrovirus MuERV-L serves as an alternative promoter for certain genes specific to the two-cell stage that are bound and induced by the transcription factor Dux [<xref ref-type="bibr" rid="CR8">8</xref>]. In humans, the evolutionarily young transposable elements such as LTR7Y, LTR7, and LTR5HS harbor binding sites for several key transcription factors and are posited to regulate both human naïve pluripotency and germline lineage commitment [<xref ref-type="bibr" rid="CR9">9</xref>–<xref ref-type="bibr" rid="CR13">13</xref>].</p>
    <p id="Par5">The study of TE functions is challenging due to their high copy numbers and their sequence repetitiveness [<xref ref-type="bibr" rid="CR7">7</xref>]. Consequently, designing sgRNAs that efficiently recruit CRISPR/Cas9 system to TEs is key for functionally probing their biological roles. Researchers have targeted individual TE copies with CRISPR/Cas9 or CRISPR inhibition (CRISPRi) systems to delete, insert, or repress specific copies, thereby studying their biological functions [<xref ref-type="bibr" rid="CR14">14</xref>–<xref ref-type="bibr" rid="CR18">18</xref>]. Moreover, there have been efforts to elucidate the functions of TE subfamilies using CRISPRi or CRISPR activation (CRISPRa), involving the design of sgRNAs that target multiple copies within certain TE subfamilies [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR20">20</xref>]. However, these attempts to manipulate TE expression via CRISPRi or CRISPRa have largely relied on sgRNAs selected using gene-centric tools and on the manual design of sgRNAs targeting consensus sequences of TE copies. Employing similar strategies, we have used CRISPRi/a to silence or activate specific TE subfamilies, assessing their potential enhancer roles in human embryonic stem cells and primordial germ cells [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>]. Nonetheless, the prevailing CRISPR design tools are primarily gene-centric and fail to provide adequate on- or off-target information for TEs, limiting in-depth TE functional studies.</p>
    <p id="Par6">In this study, we introduce CRISPR-TE, a web-based bioinformatics tool specifically for designing CRISPR/Cas sgRNAs targeting transposable elements. Our tool can design sgRNAs to target individual TE copies or combinations of sgRNAs to target TE subfamilies. Moreover, CRISPR-TE provides an interactive web interface with swift query capabilities, enabling convenient access and analysis of detailed sgRNA information for researchers. In summary, CRISPR-TE represents a valuable resource for researchers investigating the role of TEs in the genome, facilitating more comprehensive and precise studies of these repetitive elements.</p>
  </sec>
  <sec id="Sec2">
    <title>Results</title>
    <sec id="Sec3">
      <title>CRISPR-TE workflow</title>
      <p id="Par7">CRISPR-TE first constructs a database of sgRNAs by scanning human and mouse genomes for potential target sites containing the PAM (protospacer adjacent motif) sequence (5′-NGG-3′ for SpCas9 from <italic>S. pyogenes</italic>). Upon input of a genome file, the Aho-Corasick pattern matching algorithm efficiently identifies all N20NGG patterns within the reference genome [<xref ref-type="bibr" rid="CR21">21</xref>] (Fig. <xref rid="Fig1" ref-type="fig">1</xref>A). A retrieval tree (trie) data structure stores all sgRNAs, their genomic locations, and 6 bp downstream and upstream sequences (Fig. <xref rid="Fig1" ref-type="fig">1</xref>B). This data structure enables efficient computation of sequence mismatch neighborhoods. Additional data, including sgRNA on-target activity efficiency [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>], TE-specified off-target scores, TE subfamily, individual TE ID (if any), and overlapping genetic elements such as exons, introns, promoter-TSS, intergenic regions, are calculated and stored in the main database table managed by PostgreSQL. Queries for individual TE ID and their genomic coordinates are also available on the CRISPR-TE website. The sgRNA ID (gid) acts as a foreign key linking the database mismatch table, which contains gid, sgRNA sequence, and mismatch neighborhoods (Fig. <xref rid="Fig1" ref-type="fig">1</xref>C). CRISPR-TE offers two strategies for TE-specific sgRNA design: 1) targeting a single individual TE copy with minimal off-targets or 2) targeting TE subfamilies using optimized sgRNA combinations ranked by a greedy algorithm (Fig. <xref rid="Fig1" ref-type="fig">1</xref>D). These strategies provide researchers with comprehensive options for TE studies, enabling them to select the approach best suited to their experimental goals.<fig id="Fig1"><label>Fig. 1</label><caption><p>CRISPR-TE Workflow for Designing sgRNAs Targeting Transposable Elements. <bold>A</bold> Efficiently searches for all potential sgRNA target sites (N20NGG) using the Aho-Corasick algorithm on the genome FASTA file. <bold>B</bold> Employs a trie data structure to efficiently store sgRNA sequences, facilitating hamming distance mismatch searches. <bold>C</bold> Stores comprehensive sgRNA information for human and mouse genomes in a PostgreSQL database, consisting of two tables: the main table contains sgRNA sequences and coordinates, 6bp upstream and downstream sequences, on/off-target scores, genetic element classes, and the targeted TE (if applicable). <bold>D</bold> CRISPR-TE provides two approaches for sgRNA design targeting TEs: (i) targeting a single copy with minimal off-targets, and (ii) targeting a TE subfamily using optimal sgRNA combinations determined by a greedy algorithm</p></caption><graphic xlink:href="13100_2024_313_Fig1_HTML" id="MO1"/></fig></p>
    </sec>
    <sec id="Sec4">
      <title>Web interface</title>
      <p id="Par8">CRISPR-TE features a user-friendly web interface for designing sgRNAs targeting transposable elements. Users input the design objective (targeting TE single copies or subfamilies), the genome assembly (human or mouse), and the name of the targeted TE subfamily or individual TE ID (Fig. <xref rid="Fig2" ref-type="fig">2</xref>A). The annotation query function on the CRISPR-TE website allows users to search for specific genomic coordinate or individual TE IDs (Fig. <xref rid="Fig2" ref-type="fig">2</xref>B). After submitting the sgRNAs design, CRISPR-TE generates an interactive table displaying sgRNA sequences, coordinates, potential off-target numbers with 0, 1, 2, or 3 mismatches, and on/off-target activity scores (Fig. <xref rid="Fig2" ref-type="fig">2</xref>C). Detailed sgRNA information becomes accessible to users by clicking on each row in the summary table. A color-coded graphical representation of the sgRNA target site help users inspect candidate sgRNAs based on their locations (Fig. <xref rid="Fig2" ref-type="fig">2</xref>D). Summary pie charts depict the proportions of target sites by mismatch number and lists of off-target sgRNAs with their sequences and target sites further aid in the selection of suitable sgRNAs (Fig. <xref rid="Fig2" ref-type="fig">2</xref>D). For designing sgRNAs for TE subfamilies, CRISPR-TE generates combinations intended to maximize coverage of the queried TE subfamily. To balance coverage and computational complexity, CRISPR-TE currently supports designing combinations of three sgRNAs. Pie charts and bar plots visualize the proportion of on-target sites and the number of off-target sites for each sgRNA (Fig. <xref rid="Fig2" ref-type="fig">2</xref>E). Users can download the results in Excel, CSV, and PDF format for further analysis and documentation.<fig id="Fig2"><label>Fig. 2</label><caption><p>Screenshot of The CRISPR-TE Web Tool Interface. <bold>A</bold> The CRISPR-TE homepage, which requires three types of input: (i) Design purpose, (ii) Genome assembly, and (iii) Target TE copy ID or genomic coordinates. <bold>B</bold> Tool is provided for querying individual TE copy IDs and their genomic coordinates. <bold>C</bold> After submitting, CRISPR-TE displays all possible sgRNAs along with detailed information, including sgRNA sequence, coordinates, GC content, mismatches, on-target score, and off-target score. <bold>D</bold> CRISPR-TE enables users to examine the locations of sgRNAs on the genome, alongside other genomic features, by clicking on individual sgRNAs. The pie chart on the left illustrates the proportions of target sites with various mismatch counts. A list of all off-target sgRNA, including their sequences, genomic coordinates, and associated genetic element classes, is shown on the right. <bold>E</bold> The results for sgRNA combinations targeting TE subfamilies are presented. This includes the sgRNA sequences, the number of on-target sites, the on-target percentage for the queried TE subfamily, the sgRNA combination coverage, and off-targets on TEs and other genetic element classes</p></caption><graphic xlink:href="13100_2024_313_Fig2_HTML" id="MO2"/></fig></p>
    </sec>
    <sec id="Sec5">
      <title>TE sgRNA analysis of human and mouse</title>
      <p id="Par9">As TEs integrate into the genome, their sequences diverge due to the accumulation of random mutations and truncations. Evolutionarily young subfamilies, often considered as currently or recently active, possess highly similar sequences across different copies. In contrast, sequences of evolutionarily old subfamilies typically exhibit a greater degree of divergence from their consensus sequences [<xref ref-type="bibr" rid="CR24">24</xref>]. We analyzed the percentage copies covered by three sgRNA combinations for all TE subfamilies. As anticipated, sgRNA combinations designed by CRISPR-TE target evolutionarily young families such as LTR7Y, LTR5HS, SVA-D in humans with higher coverage compared to older families (Fig. <xref rid="Fig3" ref-type="fig">3</xref>A and Fig. S<xref rid="MOESM1" ref-type="media">1</xref>). Specifically, in humans, young TE subfamilies like ERVK and SVA show over 50% coverage with three sgRNAs. Similarly, in mice, B2 and ERVK rank as the top covered TE subfamilies (Fig. <xref rid="Fig3" ref-type="fig">3</xref>B). Furthermore, we discovered that evolutionarily young TEs in human and mouse, such as LTR5HS (coverage ranked at 15 in human TE subfamilies) and RLTR6CMm (coverage ranked at 22 in mouse TE subfamilies), can be targeted with over 70% coverage using CRISPR-TE-designed sgRNA combinations at the subfamily level, despite the possibility that some sgRNAs may also target other TE subfamilies with similar sequences (Fig. <xref rid="Fig3" ref-type="fig">3</xref>C). Conversely, for other relatively older TEs such as L1PA10  (coverage ranked at 223 for human TE subfamilies) and B2Mm2 (coverage ranked at 201 for mouse TE subfamilies), CRISPR-TE-designed sgRNA combinations can target only about 20% of copies, although the majority of the designed sgRNAs accurately target the intended TEs (Fig. <xref rid="Fig3" ref-type="fig">3</xref>C). In conclusion, the effectiveness of sgRNA targeting by CRISPR-TE is strongly correlated with the age of the TE, with younger TEs being more amenable to efficient targeting.<fig id="Fig3"><label>Fig. 3</label><caption><p>Analysis of TE sgRNAs in Human and Mouse. <bold>A</bold> Displays the top 20 TE subfamilies with the highest coverage using the best three sgRNA combinations in human (left panel) and mouse (right panel). <bold>B</bold> Box plots showing the coverage achieved by the best three sgRNA combinations in each TE family for human (left panel) and mouse (right panel). <bold>C</bold>. Examples of sgRNAs designed by CRISPR-TE for targeting LTR5HS (upper left panel), L1PA10 (upper right panel), RLTR6BMm (bottom left panel), and B2Mm2 (bottom right panel) TEs. The bar plots indicate the targeted percentage of copies for the top three TE subfamilies using the best three sgRNA combinations. The pie charts represent the genomic distribution of all targeted sites by the corresponding best three sgRNA combinations</p></caption><graphic xlink:href="13100_2024_313_Fig3_HTML" id="MO3"/></fig></p>
    </sec>
  </sec>
  <sec id="Sec6">
    <title>Discussion</title>
    <p id="Par10">This study introduces CRISPR-TE, a specialized sgRNA design tool tailored for the unique challenges associated with TE targeting in genome editing. Our novel approach for sgRNA design offers a significant advancement over traditional gene-targeting tools, addressing the high copy number and sequence repetitiveness that have long hindered effective TE manipulation. Our results indicate that CRISPR-TE can accurately target TE subfamilies, particularly those that are evolutionarily young and exhibit conserved sequences. The tool’s ability to target these TEs with higher coverage suggests that CRISPR-TE is adept at identifying and leveraging the less divergent sequences within these younger subfamilies. This is a crucial development, as it facilitates the functional analysis of TEs that may play significant roles in gene regulation and genome architecture.</p>
    <p id="Par11">While CRISPR-TE has shown promising results, we recognize certain limitations in its current iteration. At present, CRISPR-TE is tailored only to human and mouse genomes using SpCas9. Given the ubiquitous presence and regulatory significance of TEs in various plant species, including maize, where they play a pivotal role in phenotypic regulation [<xref ref-type="bibr" rid="CR25">25</xref>], future enhancements will aim to broaden the tool’s species compatibility and include additional Cas enzymes like Cas12 or Cas13 orthologues [<xref ref-type="bibr" rid="CR26">26</xref>]. We are committed to extending CRISPR-TE’s functionality to encompass a wider array of species and Cas variants in our subsequent updates.</p>
    <p id="Par12">The current version supports three sgRNA combinations for targeting TE subfamilies, primarily to manage the computational complexity, which grows exponentially with additional sgRNAs. This limitation may restrict the tool’s effectiveness, particularly when addressing evolutionarily older TE subfamilies that require more comprehensive sgRNA coverage. To overcome this, future development will focus on refining our greedy algorithm to allow for an increased number of sgRNA combinations, which could enhance the scope of TE subfamily targeting. However, the experimental delivery of multiple sgRNAs into cellular systems or animal models poses its own set of challenges [<xref ref-type="bibr" rid="CR27">27</xref>], particularly when investigating TE subfamily functions.</p>
    <p id="Par13">Furthermore, the potential for off-target effects is an inherent concern due to the repetitive nature of TE sequences. Although CRISPR-TE includes an on-target and off-target scoring system, these algorithms were originally developed for gene targeting and may not be fully optimized for TEs [<xref ref-type="bibr" rid="CR28">28</xref>]. Advances in the specificity of on-target and off-target predictions for TEs remain a priority for future refinement. The incorporation of machine learning algorithms is anticipated to improve the precision of sgRNA efficacy predictions, thereby mitigating the risk of off-target effects [<xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR30">30</xref>].</p>
    <p id="Par14">In conclusion, CRISPR-TE represents a notable step forward in the field of genome engineering, allowing researchers to explore the possible functions of TEs using genome editing tools. As we further imrpove this tool, we anticipate it to become an essential resource for TE research, providing deeper insights in understanding the repetitive elements in the genome.</p>
  </sec>
  <sec id="Sec7">
    <title>Methods</title>
    <sec id="Sec8">
      <title>sgRNA sequence search, annotation, and storage</title>
      <p id="Par15">We utilized the Aho-Corasick string matching algorithm to screen the genome sequences for all occurrences of the N20NGG pattern on both positive and negative strands. We then saved all potential sgRNA sequences into a modified Trie tree data structure. These sequences were classified based on various genetic elements, such as exons, introns, promoter-TSS, and intergenic regions. The genome assembly and annotation versions used were GRCh38.97 for human (<ext-link ext-link-type="uri" xlink:href="http://www.ensembl.org/Homo_sapiens/">http://www.ensembl.org/Homo_sapiens/</ext-link>) and GRCm38.97 for mouse (<ext-link ext-link-type="uri" xlink:href="https://www.ensembl.org/Mus_musculus/">https://www.ensembl.org/Mus_musculus/</ext-link>). We obtained annotations for transposable element (TE) subfamilies and individual TE IDs from RepeatMasker (<ext-link ext-link-type="uri" xlink:href="https://www.repeatmasker.org/">https://www.repeatmasker.org/</ext-link>). Using Trie tree structure, we performed mismatched string pattern matching to identify N20NGG sequences with fewer than 3 mismatched nucleotides in the genome for each sgRNA. We stored the resulting nucleotide sequences, their genomic coordinates, annotations, and mismatch information in a PostgreSQL (version 14.3) database for efficient indexing and rapid searching.</p>
    </sec>
    <sec id="Sec9">
      <title>sgRNA combination search and off-target score</title>
      <p id="Par16">We proposed a computation time-optimized greedy search algorithm to identify all potential sgRNA combinations that can cover most copies of a TE subfamily while ensuring a minimum number of off-target sites in other genetic elements. We ranked all sgRNAs targeting any copies of each TE subfamily based on their total coverage of copies. The sgRNA combination score was computed as a weighted sum of coverage and off-target events, defined by:</p>
      <p id="Par17">
        <disp-formula id="Equa">
          <alternatives>
            <tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$SCORE\;=\;Coverage-\;\lambda_1\;\times\;W_1\;-\lambda_2\;\times\;\left(\lambda_3\;\times\;W_2\;+\;\lambda_4\;\times\;W_3\;+\;\lambda_5\;\times W_4\;+\;\lambda_6\;\times W_5\right)$$\end{document}</tex-math>
            <mml:math id="M2" display="block">
              <mml:mrow>
                <mml:mi>S</mml:mi>
                <mml:mi>C</mml:mi>
                <mml:mi>O</mml:mi>
                <mml:mi>R</mml:mi>
                <mml:mi>E</mml:mi>
                <mml:mspace width="0.277778em"/>
                <mml:mo>=</mml:mo>
                <mml:mspace width="0.277778em"/>
                <mml:mi>C</mml:mi>
                <mml:mi>o</mml:mi>
                <mml:mi>v</mml:mi>
                <mml:mi>e</mml:mi>
                <mml:mi>r</mml:mi>
                <mml:mi>a</mml:mi>
                <mml:mi>g</mml:mi>
                <mml:mi>e</mml:mi>
                <mml:mo>-</mml:mo>
                <mml:mspace width="0.277778em"/>
                <mml:msub>
                  <mml:mi>λ</mml:mi>
                  <mml:mn>1</mml:mn>
                </mml:msub>
                <mml:mspace width="0.277778em"/>
                <mml:mo>×</mml:mo>
                <mml:mspace width="0.277778em"/>
                <mml:msub>
                  <mml:mi>W</mml:mi>
                  <mml:mn>1</mml:mn>
                </mml:msub>
                <mml:mspace width="0.277778em"/>
                <mml:mo>-</mml:mo>
                <mml:msub>
                  <mml:mi>λ</mml:mi>
                  <mml:mn>2</mml:mn>
                </mml:msub>
                <mml:mspace width="0.277778em"/>
                <mml:mo>×</mml:mo>
                <mml:mspace width="0.277778em"/>
                <mml:mfenced close=")" open="(">
                  <mml:msub>
                    <mml:mi>λ</mml:mi>
                    <mml:mn>3</mml:mn>
                  </mml:msub>
                  <mml:mspace width="0.277778em"/>
                  <mml:mo>×</mml:mo>
                  <mml:mspace width="0.277778em"/>
                  <mml:msub>
                    <mml:mi>W</mml:mi>
                    <mml:mn>2</mml:mn>
                  </mml:msub>
                  <mml:mspace width="0.277778em"/>
                  <mml:mo>+</mml:mo>
                  <mml:mspace width="0.277778em"/>
                  <mml:msub>
                    <mml:mi>λ</mml:mi>
                    <mml:mn>4</mml:mn>
                  </mml:msub>
                  <mml:mspace width="0.277778em"/>
                  <mml:mo>×</mml:mo>
                  <mml:mspace width="0.277778em"/>
                  <mml:msub>
                    <mml:mi>W</mml:mi>
                    <mml:mn>3</mml:mn>
                  </mml:msub>
                  <mml:mspace width="0.277778em"/>
                  <mml:mo>+</mml:mo>
                  <mml:mspace width="0.277778em"/>
                  <mml:msub>
                    <mml:mi>λ</mml:mi>
                    <mml:mn>5</mml:mn>
                  </mml:msub>
                  <mml:mspace width="0.277778em"/>
                  <mml:mo>×</mml:mo>
                  <mml:msub>
                    <mml:mi>W</mml:mi>
                    <mml:mn>4</mml:mn>
                  </mml:msub>
                  <mml:mspace width="0.277778em"/>
                  <mml:mo>+</mml:mo>
                  <mml:mspace width="0.277778em"/>
                  <mml:msub>
                    <mml:mi>λ</mml:mi>
                    <mml:mn>6</mml:mn>
                  </mml:msub>
                  <mml:mspace width="0.277778em"/>
                  <mml:mo>×</mml:mo>
                  <mml:msub>
                    <mml:mi>W</mml:mi>
                    <mml:mn>5</mml:mn>
                  </mml:msub>
                </mml:mfenced>
              </mml:mrow>
            </mml:math>
            <graphic xlink:href="13100_2024_313_Article_Equa.gif" position="anchor"/>
          </alternatives>
        </disp-formula>
      </p>
      <p id="Par18">where coverage is the percentage of TE subfamily copies covered by the current sgRNA combination, <italic>W</italic><sub>1</sub> is the number of off-target TEs, <italic>W</italic><sub>2</sub> is the number of off-targets to promoter-TSS, <italic>W</italic><sub>3</sub> is the number of off-target exons, <italic>W</italic><sub>4</sub> is the number of off-target introns, <italic>W</italic><sub>5</sub> is the number of off-target intergenic regions, with weights λ<sub>1</sub> = 1e-3, λ<sub>2</sub> = 1e-4, λ<sub>3</sub> = 0.4, λ<sub>4</sub> = 0.3, λ<sub>5</sub> = 0.4, λ<sub>6</sub> = 0.3, set as default parameters.</p>
      <p id="Par19">We employed a greedy search strategy that involved selecting the top n sgRNAs with the highest combination scores and subsequently ranking the remaining sgRNAs by the increment of the combination score. We greedily added the most optimal sgRNAs to the current combination at each iteration to obtain the final combination of sgRNAs for targeting copies of a TE subfamily.</p>
    </sec>
    <sec id="Sec10">
      <title>Implementation of the CRISPR-TE web server</title>
      <p id="Par20">We developed a web server that enables users to search for sgRNAs targeting TEs, using an intuitive and user-friendly data browser. The front-end interface of the web server was created with HTML5 and CSS3, and all data visualizations were produced using the D3.js framework [<xref ref-type="bibr" rid="CR31">31</xref>]. The back-end data, containing sgRNA sequences and annotations, was managed by the PostgreSQL database system, facilitating prompt responses to user queries. Python3 (v3.9.12) and Django (v3.2.5) were used for communication between the front-end and back-end. The website is accessible at <ext-link ext-link-type="uri" xlink:href="https://www.crisprte.cn/">https://www.crisprte.cn/</ext-link> without the need for registration or login. The CRISPR-TE website’s functionality was thoroughly tested on Google Chrome and Apple Safari browsers. The site is deployed on an Nginx web server (v1.18.0) running on a Linux Ubuntu (v20.04.5 LTS) cloud server system.</p>
    </sec>
  </sec>
  <sec sec-type="supplementary-material">
    <sec id="Sec11">
      <title>Supplementary Information</title>
      <p>
        <supplementary-material content-type="local-data" id="MOESM1">
          <media xlink:href="13100_2024_313_MOESM1_ESM.pdf">
            <caption>
              <p><bold>Additional file 1: Figure S1.</bold> sgRNA Combinations Targeting TE Subfamilies in Human and Mouse. All TE subfamilies are ranked by the targeted coverage using the best sgRNA combinations for human (left panel) and mouse (right panel).</p>
            </caption>
          </media>
        </supplementary-material>
      </p>
    </sec>
  </sec>
</body>
<back>
  <fn-group>
    <fn>
      <p>
        <bold>Publisher’s Note</bold>
      </p>
      <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
    </fn>
  </fn-group>
  <ack>
    <p>We thank all members from the Liu lab at ZJU-UoE institute for their valuable discussions and suggestions. We thank Zhou Yuxin, Qiu Yanran, and Zhang Yiwei for their preliminary exploration of the study. We would like to thank the technical support provided by the Core Facilities, especially the ZJE server of ZJU-UoE institute.</p>
  </ack>
  <notes notes-type="author-contribution">
    <title>Authors’ contributions</title>
    <p>W.L., Y.G., and Z.X. conceptualized the study and developed the experimental approach. Y.G., Z.X., and W.L. wrote the manuscript. Z.X. and Y.G. created the web application. Z.X., Y.G., S.J., M.G, and X.W. executed the algorithm and conducted the bioinformatics analysis. All authors participated in the critical review and revisions of the manuscript.</p>
  </notes>
  <notes notes-type="funding-information">
    <title>Funding</title>
    <p>This work is supported by National Natural Science Foundation of China 32170551 (to W.L.).</p>
  </notes>
  <notes notes-type="data-availability">
    <title>Availability of data and materials</title>
    <p>The CRISPR-TE web tool is publicly available at <ext-link ext-link-type="uri" xlink:href="https://www.crisprte.cn/">https://www.crisprte.cn/</ext-link>. The source code of CRISPR-TE is accessible at <ext-link ext-link-type="uri" xlink:href="https://github.com/WanluLiuLab/CRISPRTE/">https://github.com/WanluLiuLab/CRISPRTE/</ext-link>.</p>
  </notes>
  <notes>
    <title>Declarations</title>
    <notes id="FPar1">
      <title>Ethics approval and consent to participate</title>
      <p id="Par21">Not applicable.</p>
    </notes>
    <notes id="FPar2">
      <title>Consent for publication</title>
      <p id="Par22">Not applicable.</p>
    </notes>
    <notes id="FPar3" notes-type="COI-statement">
      <title>Competing interests</title>
      <p id="Par23">The authors declare no competing interests.</p>
    </notes>
  </notes>
  <ref-list id="Bib1">
    <title>References</title>
    <ref id="CR1">
      <label>1.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Jinek</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Chylinski</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Fonfara</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Hauer</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Doudna</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Charpentier</surname>
            <given-names>E</given-names>
          </name>
        </person-group>
        <article-title>A programmable dual-RNA–guided DNA endonuclease in adaptive bacterial immunity</article-title>
        <source>Science.</source>
        <year>2012</year>
        <volume>337</volume>
        <fpage>816</fpage>
        <lpage>821</lpage>
        <pub-id pub-id-type="doi">10.1126/science.1225829</pub-id>
        <?supplied-pmid 22745249?>
        <pub-id pub-id-type="pmid">22745249</pub-id>
      </element-citation>
    </ref>
    <ref id="CR2">
      <label>2.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Cong</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Ran</surname>
            <given-names>FA</given-names>
          </name>
          <name>
            <surname>Cox</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Lin</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Barretto</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Habib</surname>
            <given-names>N</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Multiplex genome engineering using CRISPR/Cas systems</article-title>
        <source>Science.</source>
        <year>2013</year>
        <volume>339</volume>
        <fpage>819</fpage>
        <lpage>823</lpage>
        <pub-id pub-id-type="doi">10.1126/science.1231143</pub-id>
        <?supplied-pmid 23287718?>
        <pub-id pub-id-type="pmid">23287718</pub-id>
      </element-citation>
    </ref>
    <ref id="CR3">
      <label>3.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gilbert</surname>
            <given-names>LA</given-names>
          </name>
          <name>
            <surname>Horlbeck</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Adamson</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Villalta</surname>
            <given-names>JE</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Whitehead</surname>
            <given-names>EH</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Genome-scale CRISPR-mediated control of gene repression and activation</article-title>
        <source>Cell.</source>
        <year>2014</year>
        <volume>159</volume>
        <fpage>647</fpage>
        <lpage>661</lpage>
        <pub-id pub-id-type="doi">10.1016/j.cell.2014.09.029</pub-id>
        <?supplied-pmid 25307932?>
        <pub-id pub-id-type="pmid">25307932</pub-id>
      </element-citation>
    </ref>
    <ref id="CR4">
      <label>4.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Konermann</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Brigham</surname>
            <given-names>MD</given-names>
          </name>
          <name>
            <surname>Trevino</surname>
            <given-names>AE</given-names>
          </name>
          <name>
            <surname>Joung</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Abudayyeh</surname>
            <given-names>OO</given-names>
          </name>
          <name>
            <surname>Barcena</surname>
            <given-names>C</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex</article-title>
        <source>Nature.</source>
        <year>2015</year>
        <volume>517</volume>
        <fpage>583</fpage>
        <lpage>588</lpage>
        <pub-id pub-id-type="doi">10.1038/nature14136</pub-id>
        <?supplied-pmid 25494202?>
        <pub-id pub-id-type="pmid">25494202</pub-id>
      </element-citation>
    </ref>
    <ref id="CR5">
      <label>5.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Komor</surname>
            <given-names>AC</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>YB</given-names>
          </name>
          <name>
            <surname>Packer</surname>
            <given-names>MS</given-names>
          </name>
          <name>
            <surname>Zuris</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>DR</given-names>
          </name>
        </person-group>
        <article-title>Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage</article-title>
        <source>Nature.</source>
        <year>2016</year>
        <volume>533</volume>
        <fpage>420</fpage>
        <lpage>424</lpage>
        <pub-id pub-id-type="doi">10.1038/nature17946</pub-id>
        <?supplied-pmid 27096365?>
        <pub-id pub-id-type="pmid">27096365</pub-id>
      </element-citation>
    </ref>
    <ref id="CR6">
      <label>6.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wells</surname>
            <given-names>JN</given-names>
          </name>
          <name>
            <surname>Feschotte</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <article-title>A field guide to eukaryotic transposable elements</article-title>
        <source>Annu Rev Genet.</source>
        <year>2020</year>
        <volume>54</volume>
        <fpage>539</fpage>
        <lpage>561</lpage>
        <pub-id pub-id-type="doi">10.1146/annurev-genet-040620-022145</pub-id>
        <?supplied-pmid 32955944?>
        <pub-id pub-id-type="pmid">32955944</pub-id>
      </element-citation>
    </ref>
    <ref id="CR7">
      <label>7.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Fueyo</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Judd</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Feschotte</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Wysocka</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Roles of transposable elements in the regulation of mammalian transcription</article-title>
        <source>Nat Rev Mol Cell Biol.</source>
        <year>2022</year>
        <volume>23</volume>
        <fpage>481</fpage>
        <lpage>497</lpage>
        <pub-id pub-id-type="doi">10.1038/s41580-022-00457-y</pub-id>
        <?supplied-pmid 35228718?>
        <pub-id pub-id-type="pmid">35228718</pub-id>
      </element-citation>
    </ref>
    <ref id="CR8">
      <label>8.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Macfarlan</surname>
            <given-names>TS</given-names>
          </name>
          <name>
            <surname>Gifford</surname>
            <given-names>WD</given-names>
          </name>
          <name>
            <surname>Driscoll</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Lettieri</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Rowe</surname>
            <given-names>HM</given-names>
          </name>
          <name>
            <surname>Bonanomi</surname>
            <given-names>D</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Embryonic stem cell potency fluctuates with endogenous retrovirus activity</article-title>
        <source>Nature.</source>
        <year>2012</year>
        <volume>487</volume>
        <fpage>57</fpage>
        <lpage>63</lpage>
        <pub-id pub-id-type="doi">10.1038/nature11244</pub-id>
        <?supplied-pmid 22722858?>
        <pub-id pub-id-type="pmid">22722858</pub-id>
      </element-citation>
    </ref>
    <ref id="CR9">
      <label>9.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Grow</surname>
            <given-names>EJ</given-names>
          </name>
          <name>
            <surname>Flynn</surname>
            <given-names>RA</given-names>
          </name>
          <name>
            <surname>Chavez</surname>
            <given-names>SL</given-names>
          </name>
          <name>
            <surname>Bayless</surname>
            <given-names>NL</given-names>
          </name>
          <name>
            <surname>Wossidlo</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Wesche</surname>
            <given-names>DJ</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Intrinsic retroviral reactivation in human preimplantation embryos and pluripotent cells</article-title>
        <source>Nature.</source>
        <year>2015</year>
        <volume>522</volume>
        <fpage>221</fpage>
        <lpage>225</lpage>
        <pub-id pub-id-type="doi">10.1038/nature14308</pub-id>
        <?supplied-pmid 25896322?>
        <pub-id pub-id-type="pmid">25896322</pub-id>
      </element-citation>
    </ref>
    <ref id="CR10">
      <label>10.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Göke</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Lu</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Chan</surname>
            <given-names>Y-S</given-names>
          </name>
          <name>
            <surname>Ng</surname>
            <given-names>H-H</given-names>
          </name>
          <name>
            <surname>Ly</surname>
            <given-names>L-H</given-names>
          </name>
          <name>
            <surname>Sachs</surname>
            <given-names>F</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Dynamic transcription of distinct classes of endogenous retroviral elements Marks specific populations of early human embryonic cells</article-title>
        <source>Cell Stem Cell.</source>
        <year>2015</year>
        <volume>16</volume>
        <fpage>135</fpage>
        <lpage>141</lpage>
        <pub-id pub-id-type="doi">10.1016/j.stem.2015.01.005</pub-id>
        <?supplied-pmid 25658370?>
        <pub-id pub-id-type="pmid">25658370</pub-id>
      </element-citation>
    </ref>
    <ref id="CR11">
      <label>11.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Pontis</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Planet</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Offner</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Turelli</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Duc</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Coudray</surname>
            <given-names>A</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Hominoid-specific transposable elements and KZFPs facilitate human embryonic genome activation and control transcription in naive human ESCs</article-title>
        <source>Cell Stem Cell.</source>
        <year>2019</year>
        <volume>24</volume>
        <fpage>724</fpage>
        <lpage>735.e5</lpage>
        <pub-id pub-id-type="doi">10.1016/j.stem.2019.03.012</pub-id>
        <?supplied-pmid 31006620?>
        <pub-id pub-id-type="pmid">31006620</pub-id>
      </element-citation>
    </ref>
    <ref id="CR12">
      <label>12.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Xiang</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Tao</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>DiRusso</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Hsu</surname>
            <given-names>F-M</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Xue</surname>
            <given-names>Z</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Human reproduction is regulated by retrotransposons derived from ancient Hominidae-specific viral infections</article-title>
        <source>Nat Commun.</source>
        <year>2022</year>
        <volume>13</volume>
        <fpage>463</fpage>
        <pub-id pub-id-type="doi">10.1038/s41467-022-28105-1</pub-id>
        <?supplied-pmid 35075135?>
        <pub-id pub-id-type="pmid">35075135</pub-id>
      </element-citation>
    </ref>
    <ref id="CR13">
      <label>13.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ai</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Xiang</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Xiang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Szczerbinska</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Qian</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Xu</surname>
            <given-names>X</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Krüppel-like factor 5 rewires NANOG regulatory network to activate human naive pluripotency specific LTR7Ys and promote naive pluripotency</article-title>
        <source>Cell Rep.</source>
        <year>2022</year>
        <volume>40</volume>
        <fpage>111240</fpage>
        <pub-id pub-id-type="doi">10.1016/j.celrep.2022.111240</pub-id>
        <?supplied-pmid 36001968?>
        <pub-id pub-id-type="pmid">36001968</pub-id>
      </element-citation>
    </ref>
    <ref id="CR14">
      <label>14.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chuong</surname>
            <given-names>EB</given-names>
          </name>
          <name>
            <surname>Elde</surname>
            <given-names>NC</given-names>
          </name>
          <name>
            <surname>Feschotte</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <article-title>Regulatory evolution of innate immunity through co-option of endogenous retroviruses</article-title>
        <source>Science.</source>
        <year>2016</year>
        <volume>351</volume>
        <fpage>1083</fpage>
        <lpage>1087</lpage>
        <pub-id pub-id-type="doi">10.1126/science.aad5497</pub-id>
        <?supplied-pmid 26941318?>
        <pub-id pub-id-type="pmid">26941318</pub-id>
      </element-citation>
    </ref>
    <ref id="CR15">
      <label>15.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hummel</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Hansen</surname>
            <given-names>EC</given-names>
          </name>
          <name>
            <surname>Yoveva</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Aprile-Garcia</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Hussong</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Sawarkar</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>The evolutionary capacitor HSP90 buffers the regulatory effects of mammalian endogenous retroviruses</article-title>
        <source>Nat Struct Mol Biol.</source>
        <year>2017</year>
        <volume>24</volume>
        <fpage>234</fpage>
        <lpage>242</lpage>
        <pub-id pub-id-type="doi">10.1038/nsmb.3368</pub-id>
        <?supplied-pmid 28134929?>
        <pub-id pub-id-type="pmid">28134929</pub-id>
      </element-citation>
    </ref>
    <ref id="CR16">
      <label>16.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Preissl</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Amaral</surname>
            <given-names>ML</given-names>
          </name>
          <name>
            <surname>Grinstein</surname>
            <given-names>JD</given-names>
          </name>
          <name>
            <surname>Farah</surname>
            <given-names>EN</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Transcriptionally active HERV-H retrotransposons demarcate topologically associating domains in human pluripotent stem cells</article-title>
        <source>Nat Genet.</source>
        <year>2019</year>
        <volume>51</volume>
        <fpage>1380</fpage>
        <lpage>1388</lpage>
        <pub-id pub-id-type="doi">10.1038/s41588-019-0479-7</pub-id>
        <?supplied-pmid 31427791?>
        <pub-id pub-id-type="pmid">31427791</pub-id>
      </element-citation>
    </ref>
    <ref id="CR17">
      <label>17.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Todd</surname>
            <given-names>CD</given-names>
          </name>
          <name>
            <surname>Deniz</surname>
            <given-names>Ö</given-names>
          </name>
          <name>
            <surname>Taylor</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Branco</surname>
            <given-names>MR</given-names>
          </name>
        </person-group>
        <article-title>Functional evaluation of transposable elements as enhancers in mouse embryonic and trophoblast stem cells</article-title>
        <source>eLife.</source>
        <year>2019</year>
        <volume>8</volume>
        <fpage>e44344</fpage>
        <pub-id pub-id-type="doi">10.7554/eLife.44344</pub-id>
        <?supplied-pmid 31012843?>
        <pub-id pub-id-type="pmid">31012843</pub-id>
      </element-citation>
    </ref>
    <ref id="CR18">
      <label>18.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Karamitros</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Hurst</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Marchi</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Karamichali</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Georgopoulou</surname>
            <given-names>U</given-names>
          </name>
          <name>
            <surname>Mentis</surname>
            <given-names>A</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Human endogenous retrovirus-K HML-2 integration within <italic>RASGRF2</italic> is associated with intravenous drug abuse and modulates transcription in a cell-line model</article-title>
        <source>Proc Natl Acad Sci U S A.</source>
        <year>2018</year>
        <volume>115</volume>
        <fpage>10434</fpage>
        <lpage>10439</lpage>
        <pub-id pub-id-type="doi">10.1073/pnas.1811940115</pub-id>
        <?supplied-pmid 30249655?>
        <pub-id pub-id-type="pmid">30249655</pub-id>
      </element-citation>
    </ref>
    <ref id="CR19">
      <label>19.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Fuentes</surname>
            <given-names>DR</given-names>
          </name>
          <name>
            <surname>Swigut</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Wysocka</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Systematic perturbation of retroviral LTRs reveals widespread long-range effects on human gene regulation</article-title>
        <source>eLife.</source>
        <year>2018</year>
        <volume>7</volume>
        <fpage>e35989</fpage>
        <pub-id pub-id-type="doi">10.7554/eLife.35989</pub-id>
        <?supplied-pmid 30070637?>
        <pub-id pub-id-type="pmid">30070637</pub-id>
      </element-citation>
    </ref>
    <ref id="CR20">
      <label>20.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Padmanabhan Nair</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Ciceri</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Jungverdorben</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Frishman</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Tchieu</surname>
            <given-names>J</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Activation of HERV-K (HML-2) disrupts cortical patterning and neuronal differentiation by increasing NTRK3</article-title>
        <source>Cell Stem Cell.</source>
        <year>2021</year>
        <volume>28</volume>
        <fpage>1566</fpage>
        <lpage>1581.e8</lpage>
        <pub-id pub-id-type="doi">10.1016/j.stem.2021.04.009</pub-id>
        <?supplied-pmid 33951478?>
        <pub-id pub-id-type="pmid">33951478</pub-id>
      </element-citation>
    </ref>
    <ref id="CR21">
      <label>21.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Aho</surname>
            <given-names>AV</given-names>
          </name>
          <name>
            <surname>Corasick</surname>
            <given-names>MJ</given-names>
          </name>
        </person-group>
        <article-title>Efficient string matching: an aid to bibliographic search</article-title>
        <source>Commun ACM.</source>
        <year>1975</year>
        <volume>18</volume>
        <fpage>333</fpage>
        <lpage>340</lpage>
        <pub-id pub-id-type="doi">10.1145/360825.360855</pub-id>
      </element-citation>
    </ref>
    <ref id="CR22">
      <label>22.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Moreno-Mateos</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Vejnar</surname>
            <given-names>CE</given-names>
          </name>
          <name>
            <surname>Beaudoin</surname>
            <given-names>J-D</given-names>
          </name>
          <name>
            <surname>Fernandez</surname>
            <given-names>JP</given-names>
          </name>
          <name>
            <surname>Mis</surname>
            <given-names>EK</given-names>
          </name>
          <name>
            <surname>Khokha</surname>
            <given-names>MK</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>CRISPRscan: designing highly efficient sgRNAs for CRISPR-Cas9 targeting in vivo</article-title>
        <source>Nat Methods.</source>
        <year>2015</year>
        <volume>12</volume>
        <fpage>982</fpage>
        <lpage>988</lpage>
        <pub-id pub-id-type="doi">10.1038/nmeth.3543</pub-id>
        <?supplied-pmid 26322839?>
        <pub-id pub-id-type="pmid">26322839</pub-id>
      </element-citation>
    </ref>
    <ref id="CR23">
      <label>23.</label>
      <mixed-citation publication-type="other">Mendoza BJ, Trinh CT. Enhanced guide-RNA design and targeting analysis for precise CRISPR genome editing of single and consortia of industrially relevant and non-model organisms. Bioinform. 2018;34:16–23.</mixed-citation>
    </ref>
    <ref id="CR24">
      <label>24.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lanciano</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Cristofari</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>Measuring and interpreting transposable element expression</article-title>
        <source>Nat Rev Genet.</source>
        <year>2020</year>
        <volume>21</volume>
        <fpage>721</fpage>
        <lpage>736</lpage>
        <pub-id pub-id-type="doi">10.1038/s41576-020-0251-y</pub-id>
        <?supplied-pmid 32576954?>
        <pub-id pub-id-type="pmid">32576954</pub-id>
      </element-citation>
    </ref>
    <ref id="CR25">
      <label>25.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Cuerda-Gil</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Shahid</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Slotkin</surname>
            <given-names>RK</given-names>
          </name>
        </person-group>
        <article-title>The epigenetic control of the transposable element life cycle in plant genomes and beyond</article-title>
        <source>Annu Rev Genet.</source>
        <year>2022</year>
        <volume>56</volume>
        <fpage>63</fpage>
        <lpage>87</lpage>
        <pub-id pub-id-type="doi">10.1146/annurev-genet-072920-015534</pub-id>
        <?supplied-pmid 36449356?>
        <pub-id pub-id-type="pmid">36449356</pub-id>
      </element-citation>
    </ref>
    <ref id="CR26">
      <label>26.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Pickar-Oliver</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Gersbach</surname>
            <given-names>CA</given-names>
          </name>
        </person-group>
        <article-title>The next generation of CRISPR–Cas technologies and applications</article-title>
        <source>Nat Rev Mol Cell Biol.</source>
        <year>2019</year>
        <volume>20</volume>
        <fpage>490</fpage>
        <lpage>507</lpage>
        <pub-id pub-id-type="doi">10.1038/s41580-019-0131-5</pub-id>
        <?supplied-pmid 31147612?>
        <pub-id pub-id-type="pmid">31147612</pub-id>
      </element-citation>
    </ref>
    <ref id="CR27">
      <label>27.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>McCarty</surname>
            <given-names>NS</given-names>
          </name>
          <name>
            <surname>Graham</surname>
            <given-names>AE</given-names>
          </name>
          <name>
            <surname>Studená</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Ledesma-Amaro</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>Multiplexed CRISPR technologies for gene editing and transcriptional regulation</article-title>
        <source>Nat Commun.</source>
        <year>2020</year>
        <volume>11</volume>
        <fpage>1281</fpage>
        <pub-id pub-id-type="doi">10.1038/s41467-020-15053-x</pub-id>
        <?supplied-pmid 32152313?>
        <pub-id pub-id-type="pmid">32152313</pub-id>
      </element-citation>
    </ref>
    <ref id="CR28">
      <label>28.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>T</given-names>
          </name>
        </person-group>
        <article-title>Computational approaches for effective CRISPR guide RNA design and evaluation</article-title>
        <source>Comput Struct Biotechnol J.</source>
        <year>2020</year>
        <volume>18</volume>
        <fpage>35</fpage>
        <lpage>44</lpage>
        <pub-id pub-id-type="doi">10.1016/j.csbj.2019.11.006</pub-id>
        <?supplied-pmid 31890142?>
        <pub-id pub-id-type="pmid">31890142</pub-id>
      </element-citation>
    </ref>
    <ref id="CR29">
      <label>29.</label>
      <mixed-citation publication-type="other">Abadi S, Yan WX, Amar D, Mayrose I. A machine learning approach for predicting CRISPR-Cas9 cleavage efficiencies and patterns underlying its mechanism of action. PLoS Comput Biol. 2017;13:e1005807.</mixed-citation>
    </ref>
    <ref id="CR30">
      <label>30.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chuai</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Ma</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Yan</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Hong</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Xue</surname>
            <given-names>D</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>DeepCRISPR: optimized CRISPR guide RNA design by deep learning</article-title>
        <source>Genome Biol.</source>
        <year>2018</year>
        <volume>19</volume>
        <fpage>80</fpage>
        <pub-id pub-id-type="doi">10.1186/s13059-018-1459-4</pub-id>
        <?supplied-pmid 29945655?>
        <pub-id pub-id-type="pmid">29945655</pub-id>
      </element-citation>
    </ref>
    <ref id="CR31">
      <label>31.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bostock</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Ogievetsky</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Heer</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>D<sup>3</sup> Data-Driven Documents</article-title>
        <source>IEEE Trans Vis Comput Graph.</source>
        <year>2011</year>
        <volume>17</volume>
        <fpage>2301</fpage>
        <lpage>2309</lpage>
        <pub-id pub-id-type="doi">10.1109/TVCG.2011.185</pub-id>
        <?supplied-pmid 22034350?>
        <pub-id pub-id-type="pmid">22034350</pub-id>
      </element-citation>
    </ref>
  </ref-list>
</back>
<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName A++V2.4.dtd?>
<?SourceDTD.Version 2.4?>
<?ConverterInfo.XSLTName springer2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Mob DNA</journal-id>
    <journal-id journal-id-type="iso-abbrev">Mob DNA</journal-id>
    <journal-title-group>
      <journal-title>Mobile DNA</journal-title>
    </journal-title-group>
    <issn pub-type="epub">1759-8753</issn>
    <publisher>
      <publisher-name>BioMed Central</publisher-name>
      <publisher-loc>London</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">10832116</article-id>
    <article-id pub-id-type="publisher-id">313</article-id>
    <article-id pub-id-type="doi">10.1186/s13100-024-00313-0</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Software</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>CRISPR-TE: a web-based tool to generate single guide RNAs targeting transposable elements</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Guo</surname>
          <given-names>Yixin</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Xue</surname>
          <given-names>Ziwei</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Gong</surname>
          <given-names>Meiting</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Jin</surname>
          <given-names>Siqian</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Wu</surname>
          <given-names>Xindi</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Liu</surname>
          <given-names>Wanlu</given-names>
        </name>
        <address>
          <email>wanluliu@intl.zju.edu.cn</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.13402.34</institution-id><institution-id institution-id-type="ISNI">0000 0004 1759 700X</institution-id><institution>Department of Orthopedic Surgery of the Second Affiliated Hospital, and Centre of Biomedical Systems and Informatics of Zhejiang University-University of Edinburgh Institute (ZJU-UoE Institute), Zhejiang University School of Medicine, </institution><institution>Zhejiang University, </institution></institution-wrap>Zhejiang, Hangzhou 310003 China </aff>
      <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00a2xv884</institution-id><institution-id institution-id-type="GRID">grid.13402.34</institution-id><institution-id institution-id-type="ISNI">0000 0004 1759 700X</institution-id><institution>Future Health Laboratory, Innovation Center of Yangtze River Delta, </institution><institution>Zhejiang University, </institution></institution-wrap>Jiaxing, 314100 China </aff>
    </contrib-group>
    <pub-date pub-type="epub">
      <day>1</day>
      <month>2</month>
      <year>2024</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>1</day>
      <month>2</month>
      <year>2024</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2024</year>
    </pub-date>
    <volume>15</volume>
    <elocation-id>3</elocation-id>
    <history>
      <date date-type="received">
        <day>29</day>
        <month>6</month>
        <year>2023</year>
      </date>
      <date date-type="accepted">
        <day>13</day>
        <month>1</month>
        <year>2024</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2024</copyright-statement>
      <license>
        <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p>
      </license>
    </permissions>
    <abstract id="Abs1">
      <sec>
        <title>Background</title>
        <p id="Par1">The CRISPR/Cas systems have emerged as powerful tools in genome engineering. Recent studies highlighting the crucial role of transposable elements (TEs) have stimulated research interest in manipulating these elements to understand their functions. However, designing single guide RNAs (sgRNAs) that are specific and efficient for TE manipulation is a significant challenge, given their sequence repetitiveness and high copy numbers. While various sgRNA design tools have been developed for gene editing, an optimized sgRNA designer for TE manipulation has yet to be established.</p>
      </sec>
      <sec>
        <title>Results</title>
        <p id="Par2">We present CRISPR-TE, a web-based application featuring an accessible graphical user interface, available at <ext-link ext-link-type="uri" xlink:href="https://www.crisprte.cn/">https://www.crisprte.cn/</ext-link>, and currently tailored to the human and mouse genomes. CRISPR-TE identifies all potential sgRNAs for TEs and provides a comprehensive solution for efficient TE targeting at both the single copy and subfamily levels. Our analysis shows that sgRNAs targeting TEs can more effectively target evolutionarily young TEs with conserved sequences at the subfamily level.</p>
      </sec>
      <sec>
        <title>Conclusions</title>
        <p id="Par3">CRISPR-TE offers a versatile framework for designing sgRNAs for TE targeting. CRISPR-TE is publicly accessible at <ext-link ext-link-type="uri" xlink:href="https://www.crisprte.cn/">https://www.crisprte.cn/</ext-link> as an online web service and the source code of CRISPR-TE is available at <ext-link ext-link-type="uri" xlink:href="https://github.com/WanluLiuLab/CRISPRTE/">https://github.com/WanluLiuLab/CRISPRTE/</ext-link>.</p>
      </sec>
      <sec>
        <title>Supplementary Information</title>
        <p>The online version contains supplementary material available at 10.1186/s13100-024-00313-0.</p>
      </sec>
    </abstract>
    <custom-meta-group>
      <custom-meta>
        <meta-name>issue-copyright-statement</meta-name>
        <meta-value>© BioMed Central Ltd., part of Springer Nature 2024</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="Sec1">
    <title>Introduction</title>
    <p id="Par4">Since the initial discovery of the CRISPR/Cas9 system for genome editing [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>], the development of catalytically inactive Cas9 variants has further facilitated its application in targeted gene expression activation [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>], repression [<xref ref-type="bibr" rid="CR3">3</xref>], and base editing [<xref ref-type="bibr" rid="CR5">5</xref>]. Transposable elements (TEs) are mobile DNA sequences capable of moving within the genome [<xref ref-type="bibr" rid="CR6">6</xref>]. Though once deemed “genomic dark matter”, recent studies have suggested that TEs may act as cis-regulatory elements, contributing to gene regulation by serving as promoters, enhancers, silencers, and boundary elements [<xref ref-type="bibr" rid="CR7">7</xref>]. For instance, in mouse early embryogenesis, the endogenous retrovirus MuERV-L serves as an alternative promoter for certain genes specific to the two-cell stage that are bound and induced by the transcription factor Dux [<xref ref-type="bibr" rid="CR8">8</xref>]. In humans, the evolutionarily young transposable elements such as LTR7Y, LTR7, and LTR5HS harbor binding sites for several key transcription factors and are posited to regulate both human naïve pluripotency and germline lineage commitment [<xref ref-type="bibr" rid="CR9">9</xref>–<xref ref-type="bibr" rid="CR13">13</xref>].</p>
    <p id="Par5">The study of TE functions is challenging due to their high copy numbers and their sequence repetitiveness [<xref ref-type="bibr" rid="CR7">7</xref>]. Consequently, designing sgRNAs that efficiently recruit CRISPR/Cas9 system to TEs is key for functionally probing their biological roles. Researchers have targeted individual TE copies with CRISPR/Cas9 or CRISPR inhibition (CRISPRi) systems to delete, insert, or repress specific copies, thereby studying their biological functions [<xref ref-type="bibr" rid="CR14">14</xref>–<xref ref-type="bibr" rid="CR18">18</xref>]. Moreover, there have been efforts to elucidate the functions of TE subfamilies using CRISPRi or CRISPR activation (CRISPRa), involving the design of sgRNAs that target multiple copies within certain TE subfamilies [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR20">20</xref>]. However, these attempts to manipulate TE expression via CRISPRi or CRISPRa have largely relied on sgRNAs selected using gene-centric tools and on the manual design of sgRNAs targeting consensus sequences of TE copies. Employing similar strategies, we have used CRISPRi/a to silence or activate specific TE subfamilies, assessing their potential enhancer roles in human embryonic stem cells and primordial germ cells [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>]. Nonetheless, the prevailing CRISPR design tools are primarily gene-centric and fail to provide adequate on- or off-target information for TEs, limiting in-depth TE functional studies.</p>
    <p id="Par6">In this study, we introduce CRISPR-TE, a web-based bioinformatics tool specifically for designing CRISPR/Cas sgRNAs targeting transposable elements. Our tool can design sgRNAs to target individual TE copies or combinations of sgRNAs to target TE subfamilies. Moreover, CRISPR-TE provides an interactive web interface with swift query capabilities, enabling convenient access and analysis of detailed sgRNA information for researchers. In summary, CRISPR-TE represents a valuable resource for researchers investigating the role of TEs in the genome, facilitating more comprehensive and precise studies of these repetitive elements.</p>
  </sec>
  <sec id="Sec2">
    <title>Results</title>
    <sec id="Sec3">
      <title>CRISPR-TE workflow</title>
      <p id="Par7">CRISPR-TE first constructs a database of sgRNAs by scanning human and mouse genomes for potential target sites containing the PAM (protospacer adjacent motif) sequence (5′-NGG-3′ for SpCas9 from <italic>S. pyogenes</italic>). Upon input of a genome file, the Aho-Corasick pattern matching algorithm efficiently identifies all N20NGG patterns within the reference genome [<xref ref-type="bibr" rid="CR21">21</xref>] (Fig. <xref rid="Fig1" ref-type="fig">1</xref>A). A retrieval tree (trie) data structure stores all sgRNAs, their genomic locations, and 6 bp downstream and upstream sequences (Fig. <xref rid="Fig1" ref-type="fig">1</xref>B). This data structure enables efficient computation of sequence mismatch neighborhoods. Additional data, including sgRNA on-target activity efficiency [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>], TE-specified off-target scores, TE subfamily, individual TE ID (if any), and overlapping genetic elements such as exons, introns, promoter-TSS, intergenic regions, are calculated and stored in the main database table managed by PostgreSQL. Queries for individual TE ID and their genomic coordinates are also available on the CRISPR-TE website. The sgRNA ID (gid) acts as a foreign key linking the database mismatch table, which contains gid, sgRNA sequence, and mismatch neighborhoods (Fig. <xref rid="Fig1" ref-type="fig">1</xref>C). CRISPR-TE offers two strategies for TE-specific sgRNA design: 1) targeting a single individual TE copy with minimal off-targets or 2) targeting TE subfamilies using optimized sgRNA combinations ranked by a greedy algorithm (Fig. <xref rid="Fig1" ref-type="fig">1</xref>D). These strategies provide researchers with comprehensive options for TE studies, enabling them to select the approach best suited to their experimental goals.<fig id="Fig1"><label>Fig. 1</label><caption><p>CRISPR-TE Workflow for Designing sgRNAs Targeting Transposable Elements. <bold>A</bold> Efficiently searches for all potential sgRNA target sites (N20NGG) using the Aho-Corasick algorithm on the genome FASTA file. <bold>B</bold> Employs a trie data structure to efficiently store sgRNA sequences, facilitating hamming distance mismatch searches. <bold>C</bold> Stores comprehensive sgRNA information for human and mouse genomes in a PostgreSQL database, consisting of two tables: the main table contains sgRNA sequences and coordinates, 6bp upstream and downstream sequences, on/off-target scores, genetic element classes, and the targeted TE (if applicable). <bold>D</bold> CRISPR-TE provides two approaches for sgRNA design targeting TEs: (i) targeting a single copy with minimal off-targets, and (ii) targeting a TE subfamily using optimal sgRNA combinations determined by a greedy algorithm</p></caption><graphic xlink:href="13100_2024_313_Fig1_HTML" id="MO1"/></fig></p>
    </sec>
    <sec id="Sec4">
      <title>Web interface</title>
      <p id="Par8">CRISPR-TE features a user-friendly web interface for designing sgRNAs targeting transposable elements. Users input the design objective (targeting TE single copies or subfamilies), the genome assembly (human or mouse), and the name of the targeted TE subfamily or individual TE ID (Fig. <xref rid="Fig2" ref-type="fig">2</xref>A). The annotation query function on the CRISPR-TE website allows users to search for specific genomic coordinate or individual TE IDs (Fig. <xref rid="Fig2" ref-type="fig">2</xref>B). After submitting the sgRNAs design, CRISPR-TE generates an interactive table displaying sgRNA sequences, coordinates, potential off-target numbers with 0, 1, 2, or 3 mismatches, and on/off-target activity scores (Fig. <xref rid="Fig2" ref-type="fig">2</xref>C). Detailed sgRNA information becomes accessible to users by clicking on each row in the summary table. A color-coded graphical representation of the sgRNA target site help users inspect candidate sgRNAs based on their locations (Fig. <xref rid="Fig2" ref-type="fig">2</xref>D). Summary pie charts depict the proportions of target sites by mismatch number and lists of off-target sgRNAs with their sequences and target sites further aid in the selection of suitable sgRNAs (Fig. <xref rid="Fig2" ref-type="fig">2</xref>D). For designing sgRNAs for TE subfamilies, CRISPR-TE generates combinations intended to maximize coverage of the queried TE subfamily. To balance coverage and computational complexity, CRISPR-TE currently supports designing combinations of three sgRNAs. Pie charts and bar plots visualize the proportion of on-target sites and the number of off-target sites for each sgRNA (Fig. <xref rid="Fig2" ref-type="fig">2</xref>E). Users can download the results in Excel, CSV, and PDF format for further analysis and documentation.<fig id="Fig2"><label>Fig. 2</label><caption><p>Screenshot of The CRISPR-TE Web Tool Interface. <bold>A</bold> The CRISPR-TE homepage, which requires three types of input: (i) Design purpose, (ii) Genome assembly, and (iii) Target TE copy ID or genomic coordinates. <bold>B</bold> Tool is provided for querying individual TE copy IDs and their genomic coordinates. <bold>C</bold> After submitting, CRISPR-TE displays all possible sgRNAs along with detailed information, including sgRNA sequence, coordinates, GC content, mismatches, on-target score, and off-target score. <bold>D</bold> CRISPR-TE enables users to examine the locations of sgRNAs on the genome, alongside other genomic features, by clicking on individual sgRNAs. The pie chart on the left illustrates the proportions of target sites with various mismatch counts. A list of all off-target sgRNA, including their sequences, genomic coordinates, and associated genetic element classes, is shown on the right. <bold>E</bold> The results for sgRNA combinations targeting TE subfamilies are presented. This includes the sgRNA sequences, the number of on-target sites, the on-target percentage for the queried TE subfamily, the sgRNA combination coverage, and off-targets on TEs and other genetic element classes</p></caption><graphic xlink:href="13100_2024_313_Fig2_HTML" id="MO2"/></fig></p>
    </sec>
    <sec id="Sec5">
      <title>TE sgRNA analysis of human and mouse</title>
      <p id="Par9">As TEs integrate into the genome, their sequences diverge due to the accumulation of random mutations and truncations. Evolutionarily young subfamilies, often considered as currently or recently active, possess highly similar sequences across different copies. In contrast, sequences of evolutionarily old subfamilies typically exhibit a greater degree of divergence from their consensus sequences [<xref ref-type="bibr" rid="CR24">24</xref>]. We analyzed the percentage copies covered by three sgRNA combinations for all TE subfamilies. As anticipated, sgRNA combinations designed by CRISPR-TE target evolutionarily young families such as LTR7Y, LTR5HS, SVA-D in humans with higher coverage compared to older families (Fig. <xref rid="Fig3" ref-type="fig">3</xref>A and Fig. S<xref rid="MOESM1" ref-type="media">1</xref>). Specifically, in humans, young TE subfamilies like ERVK and SVA show over 50% coverage with three sgRNAs. Similarly, in mice, B2 and ERVK rank as the top covered TE subfamilies (Fig. <xref rid="Fig3" ref-type="fig">3</xref>B). Furthermore, we discovered that evolutionarily young TEs in human and mouse, such as LTR5HS (coverage ranked at 15 in human TE subfamilies) and RLTR6CMm (coverage ranked at 22 in mouse TE subfamilies), can be targeted with over 70% coverage using CRISPR-TE-designed sgRNA combinations at the subfamily level, despite the possibility that some sgRNAs may also target other TE subfamilies with similar sequences (Fig. <xref rid="Fig3" ref-type="fig">3</xref>C). Conversely, for other relatively older TEs such as L1PA10  (coverage ranked at 223 for human TE subfamilies) and B2Mm2 (coverage ranked at 201 for mouse TE subfamilies), CRISPR-TE-designed sgRNA combinations can target only about 20% of copies, although the majority of the designed sgRNAs accurately target the intended TEs (Fig. <xref rid="Fig3" ref-type="fig">3</xref>C). In conclusion, the effectiveness of sgRNA targeting by CRISPR-TE is strongly correlated with the age of the TE, with younger TEs being more amenable to efficient targeting.<fig id="Fig3"><label>Fig. 3</label><caption><p>Analysis of TE sgRNAs in Human and Mouse. <bold>A</bold> Displays the top 20 TE subfamilies with the highest coverage using the best three sgRNA combinations in human (left panel) and mouse (right panel). <bold>B</bold> Box plots showing the coverage achieved by the best three sgRNA combinations in each TE family for human (left panel) and mouse (right panel). <bold>C</bold>. Examples of sgRNAs designed by CRISPR-TE for targeting LTR5HS (upper left panel), L1PA10 (upper right panel), RLTR6BMm (bottom left panel), and B2Mm2 (bottom right panel) TEs. The bar plots indicate the targeted percentage of copies for the top three TE subfamilies using the best three sgRNA combinations. The pie charts represent the genomic distribution of all targeted sites by the corresponding best three sgRNA combinations</p></caption><graphic xlink:href="13100_2024_313_Fig3_HTML" id="MO3"/></fig></p>
    </sec>
  </sec>
  <sec id="Sec6">
    <title>Discussion</title>
    <p id="Par10">This study introduces CRISPR-TE, a specialized sgRNA design tool tailored for the unique challenges associated with TE targeting in genome editing. Our novel approach for sgRNA design offers a significant advancement over traditional gene-targeting tools, addressing the high copy number and sequence repetitiveness that have long hindered effective TE manipulation. Our results indicate that CRISPR-TE can accurately target TE subfamilies, particularly those that are evolutionarily young and exhibit conserved sequences. The tool’s ability to target these TEs with higher coverage suggests that CRISPR-TE is adept at identifying and leveraging the less divergent sequences within these younger subfamilies. This is a crucial development, as it facilitates the functional analysis of TEs that may play significant roles in gene regulation and genome architecture.</p>
    <p id="Par11">While CRISPR-TE has shown promising results, we recognize certain limitations in its current iteration. At present, CRISPR-TE is tailored only to human and mouse genomes using SpCas9. Given the ubiquitous presence and regulatory significance of TEs in various plant species, including maize, where they play a pivotal role in phenotypic regulation [<xref ref-type="bibr" rid="CR25">25</xref>], future enhancements will aim to broaden the tool’s species compatibility and include additional Cas enzymes like Cas12 or Cas13 orthologues [<xref ref-type="bibr" rid="CR26">26</xref>]. We are committed to extending CRISPR-TE’s functionality to encompass a wider array of species and Cas variants in our subsequent updates.</p>
    <p id="Par12">The current version supports three sgRNA combinations for targeting TE subfamilies, primarily to manage the computational complexity, which grows exponentially with additional sgRNAs. This limitation may restrict the tool’s effectiveness, particularly when addressing evolutionarily older TE subfamilies that require more comprehensive sgRNA coverage. To overcome this, future development will focus on refining our greedy algorithm to allow for an increased number of sgRNA combinations, which could enhance the scope of TE subfamily targeting. However, the experimental delivery of multiple sgRNAs into cellular systems or animal models poses its own set of challenges [<xref ref-type="bibr" rid="CR27">27</xref>], particularly when investigating TE subfamily functions.</p>
    <p id="Par13">Furthermore, the potential for off-target effects is an inherent concern due to the repetitive nature of TE sequences. Although CRISPR-TE includes an on-target and off-target scoring system, these algorithms were originally developed for gene targeting and may not be fully optimized for TEs [<xref ref-type="bibr" rid="CR28">28</xref>]. Advances in the specificity of on-target and off-target predictions for TEs remain a priority for future refinement. The incorporation of machine learning algorithms is anticipated to improve the precision of sgRNA efficacy predictions, thereby mitigating the risk of off-target effects [<xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR30">30</xref>].</p>
    <p id="Par14">In conclusion, CRISPR-TE represents a notable step forward in the field of genome engineering, allowing researchers to explore the possible functions of TEs using genome editing tools. As we further imrpove this tool, we anticipate it to become an essential resource for TE research, providing deeper insights in understanding the repetitive elements in the genome.</p>
  </sec>
  <sec id="Sec7">
    <title>Methods</title>
    <sec id="Sec8">
      <title>sgRNA sequence search, annotation, and storage</title>
      <p id="Par15">We utilized the Aho-Corasick string matching algorithm to screen the genome sequences for all occurrences of the N20NGG pattern on both positive and negative strands. We then saved all potential sgRNA sequences into a modified Trie tree data structure. These sequences were classified based on various genetic elements, such as exons, introns, promoter-TSS, and intergenic regions. The genome assembly and annotation versions used were GRCh38.97 for human (<ext-link ext-link-type="uri" xlink:href="http://www.ensembl.org/Homo_sapiens/">http://www.ensembl.org/Homo_sapiens/</ext-link>) and GRCm38.97 for mouse (<ext-link ext-link-type="uri" xlink:href="https://www.ensembl.org/Mus_musculus/">https://www.ensembl.org/Mus_musculus/</ext-link>). We obtained annotations for transposable element (TE) subfamilies and individual TE IDs from RepeatMasker (<ext-link ext-link-type="uri" xlink:href="https://www.repeatmasker.org/">https://www.repeatmasker.org/</ext-link>). Using Trie tree structure, we performed mismatched string pattern matching to identify N20NGG sequences with fewer than 3 mismatched nucleotides in the genome for each sgRNA. We stored the resulting nucleotide sequences, their genomic coordinates, annotations, and mismatch information in a PostgreSQL (version 14.3) database for efficient indexing and rapid searching.</p>
    </sec>
    <sec id="Sec9">
      <title>sgRNA combination search and off-target score</title>
      <p id="Par16">We proposed a computation time-optimized greedy search algorithm to identify all potential sgRNA combinations that can cover most copies of a TE subfamily while ensuring a minimum number of off-target sites in other genetic elements. We ranked all sgRNAs targeting any copies of each TE subfamily based on their total coverage of copies. The sgRNA combination score was computed as a weighted sum of coverage and off-target events, defined by:</p>
      <p id="Par17">
        <disp-formula id="Equa">
          <alternatives>
            <tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$SCORE\;=\;Coverage-\;\lambda_1\;\times\;W_1\;-\lambda_2\;\times\;\left(\lambda_3\;\times\;W_2\;+\;\lambda_4\;\times\;W_3\;+\;\lambda_5\;\times W_4\;+\;\lambda_6\;\times W_5\right)$$\end{document}</tex-math>
            <mml:math id="M2" display="block">
              <mml:mrow>
                <mml:mi>S</mml:mi>
                <mml:mi>C</mml:mi>
                <mml:mi>O</mml:mi>
                <mml:mi>R</mml:mi>
                <mml:mi>E</mml:mi>
                <mml:mspace width="0.277778em"/>
                <mml:mo>=</mml:mo>
                <mml:mspace width="0.277778em"/>
                <mml:mi>C</mml:mi>
                <mml:mi>o</mml:mi>
                <mml:mi>v</mml:mi>
                <mml:mi>e</mml:mi>
                <mml:mi>r</mml:mi>
                <mml:mi>a</mml:mi>
                <mml:mi>g</mml:mi>
                <mml:mi>e</mml:mi>
                <mml:mo>-</mml:mo>
                <mml:mspace width="0.277778em"/>
                <mml:msub>
                  <mml:mi>λ</mml:mi>
                  <mml:mn>1</mml:mn>
                </mml:msub>
                <mml:mspace width="0.277778em"/>
                <mml:mo>×</mml:mo>
                <mml:mspace width="0.277778em"/>
                <mml:msub>
                  <mml:mi>W</mml:mi>
                  <mml:mn>1</mml:mn>
                </mml:msub>
                <mml:mspace width="0.277778em"/>
                <mml:mo>-</mml:mo>
                <mml:msub>
                  <mml:mi>λ</mml:mi>
                  <mml:mn>2</mml:mn>
                </mml:msub>
                <mml:mspace width="0.277778em"/>
                <mml:mo>×</mml:mo>
                <mml:mspace width="0.277778em"/>
                <mml:mfenced close=")" open="(">
                  <mml:msub>
                    <mml:mi>λ</mml:mi>
                    <mml:mn>3</mml:mn>
                  </mml:msub>
                  <mml:mspace width="0.277778em"/>
                  <mml:mo>×</mml:mo>
                  <mml:mspace width="0.277778em"/>
                  <mml:msub>
                    <mml:mi>W</mml:mi>
                    <mml:mn>2</mml:mn>
                  </mml:msub>
                  <mml:mspace width="0.277778em"/>
                  <mml:mo>+</mml:mo>
                  <mml:mspace width="0.277778em"/>
                  <mml:msub>
                    <mml:mi>λ</mml:mi>
                    <mml:mn>4</mml:mn>
                  </mml:msub>
                  <mml:mspace width="0.277778em"/>
                  <mml:mo>×</mml:mo>
                  <mml:mspace width="0.277778em"/>
                  <mml:msub>
                    <mml:mi>W</mml:mi>
                    <mml:mn>3</mml:mn>
                  </mml:msub>
                  <mml:mspace width="0.277778em"/>
                  <mml:mo>+</mml:mo>
                  <mml:mspace width="0.277778em"/>
                  <mml:msub>
                    <mml:mi>λ</mml:mi>
                    <mml:mn>5</mml:mn>
                  </mml:msub>
                  <mml:mspace width="0.277778em"/>
                  <mml:mo>×</mml:mo>
                  <mml:msub>
                    <mml:mi>W</mml:mi>
                    <mml:mn>4</mml:mn>
                  </mml:msub>
                  <mml:mspace width="0.277778em"/>
                  <mml:mo>+</mml:mo>
                  <mml:mspace width="0.277778em"/>
                  <mml:msub>
                    <mml:mi>λ</mml:mi>
                    <mml:mn>6</mml:mn>
                  </mml:msub>
                  <mml:mspace width="0.277778em"/>
                  <mml:mo>×</mml:mo>
                  <mml:msub>
                    <mml:mi>W</mml:mi>
                    <mml:mn>5</mml:mn>
                  </mml:msub>
                </mml:mfenced>
              </mml:mrow>
            </mml:math>
            <graphic xlink:href="13100_2024_313_Article_Equa.gif" position="anchor"/>
          </alternatives>
        </disp-formula>
      </p>
      <p id="Par18">where coverage is the percentage of TE subfamily copies covered by the current sgRNA combination, <italic>W</italic><sub>1</sub> is the number of off-target TEs, <italic>W</italic><sub>2</sub> is the number of off-targets to promoter-TSS, <italic>W</italic><sub>3</sub> is the number of off-target exons, <italic>W</italic><sub>4</sub> is the number of off-target introns, <italic>W</italic><sub>5</sub> is the number of off-target intergenic regions, with weights λ<sub>1</sub> = 1e-3, λ<sub>2</sub> = 1e-4, λ<sub>3</sub> = 0.4, λ<sub>4</sub> = 0.3, λ<sub>5</sub> = 0.4, λ<sub>6</sub> = 0.3, set as default parameters.</p>
      <p id="Par19">We employed a greedy search strategy that involved selecting the top n sgRNAs with the highest combination scores and subsequently ranking the remaining sgRNAs by the increment of the combination score. We greedily added the most optimal sgRNAs to the current combination at each iteration to obtain the final combination of sgRNAs for targeting copies of a TE subfamily.</p>
    </sec>
    <sec id="Sec10">
      <title>Implementation of the CRISPR-TE web server</title>
      <p id="Par20">We developed a web server that enables users to search for sgRNAs targeting TEs, using an intuitive and user-friendly data browser. The front-end interface of the web server was created with HTML5 and CSS3, and all data visualizations were produced using the D3.js framework [<xref ref-type="bibr" rid="CR31">31</xref>]. The back-end data, containing sgRNA sequences and annotations, was managed by the PostgreSQL database system, facilitating prompt responses to user queries. Python3 (v3.9.12) and Django (v3.2.5) were used for communication between the front-end and back-end. The website is accessible at <ext-link ext-link-type="uri" xlink:href="https://www.crisprte.cn/">https://www.crisprte.cn/</ext-link> without the need for registration or login. The CRISPR-TE website’s functionality was thoroughly tested on Google Chrome and Apple Safari browsers. The site is deployed on an Nginx web server (v1.18.0) running on a Linux Ubuntu (v20.04.5 LTS) cloud server system.</p>
    </sec>
  </sec>
  <sec sec-type="supplementary-material">
    <sec id="Sec11">
      <title>Supplementary Information</title>
      <p>
        <supplementary-material content-type="local-data" id="MOESM1">
          <media xlink:href="13100_2024_313_MOESM1_ESM.pdf">
            <caption>
              <p><bold>Additional file 1: Figure S1.</bold> sgRNA Combinations Targeting TE Subfamilies in Human and Mouse. All TE subfamilies are ranked by the targeted coverage using the best sgRNA combinations for human (left panel) and mouse (right panel).</p>
            </caption>
          </media>
        </supplementary-material>
      </p>
    </sec>
  </sec>
</body>
<back>
  <fn-group>
    <fn>
      <p>
        <bold>Publisher’s Note</bold>
      </p>
      <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
    </fn>
  </fn-group>
  <ack>
    <p>We thank all members from the Liu lab at ZJU-UoE institute for their valuable discussions and suggestions. We thank Zhou Yuxin, Qiu Yanran, and Zhang Yiwei for their preliminary exploration of the study. We would like to thank the technical support provided by the Core Facilities, especially the ZJE server of ZJU-UoE institute.</p>
  </ack>
  <notes notes-type="author-contribution">
    <title>Authors’ contributions</title>
    <p>W.L., Y.G., and Z.X. conceptualized the study and developed the experimental approach. Y.G., Z.X., and W.L. wrote the manuscript. Z.X. and Y.G. created the web application. Z.X., Y.G., S.J., M.G, and X.W. executed the algorithm and conducted the bioinformatics analysis. All authors participated in the critical review and revisions of the manuscript.</p>
  </notes>
  <notes notes-type="funding-information">
    <title>Funding</title>
    <p>This work is supported by National Natural Science Foundation of China 32170551 (to W.L.).</p>
  </notes>
  <notes notes-type="data-availability">
    <title>Availability of data and materials</title>
    <p>The CRISPR-TE web tool is publicly available at <ext-link ext-link-type="uri" xlink:href="https://www.crisprte.cn/">https://www.crisprte.cn/</ext-link>. The source code of CRISPR-TE is accessible at <ext-link ext-link-type="uri" xlink:href="https://github.com/WanluLiuLab/CRISPRTE/">https://github.com/WanluLiuLab/CRISPRTE/</ext-link>.</p>
  </notes>
  <notes>
    <title>Declarations</title>
    <notes id="FPar1">
      <title>Ethics approval and consent to participate</title>
      <p id="Par21">Not applicable.</p>
    </notes>
    <notes id="FPar2">
      <title>Consent for publication</title>
      <p id="Par22">Not applicable.</p>
    </notes>
    <notes id="FPar3" notes-type="COI-statement">
      <title>Competing interests</title>
      <p id="Par23">The authors declare no competing interests.</p>
    </notes>
  </notes>
  <ref-list id="Bib1">
    <title>References</title>
    <ref id="CR1">
      <label>1.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Jinek</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Chylinski</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Fonfara</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Hauer</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Doudna</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Charpentier</surname>
            <given-names>E</given-names>
          </name>
        </person-group>
        <article-title>A programmable dual-RNA–guided DNA endonuclease in adaptive bacterial immunity</article-title>
        <source>Science.</source>
        <year>2012</year>
        <volume>337</volume>
        <fpage>816</fpage>
        <lpage>821</lpage>
        <pub-id pub-id-type="doi">10.1126/science.1225829</pub-id>
        <?supplied-pmid 22745249?>
        <pub-id pub-id-type="pmid">22745249</pub-id>
      </element-citation>
    </ref>
    <ref id="CR2">
      <label>2.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Cong</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Ran</surname>
            <given-names>FA</given-names>
          </name>
          <name>
            <surname>Cox</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Lin</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Barretto</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Habib</surname>
            <given-names>N</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Multiplex genome engineering using CRISPR/Cas systems</article-title>
        <source>Science.</source>
        <year>2013</year>
        <volume>339</volume>
        <fpage>819</fpage>
        <lpage>823</lpage>
        <pub-id pub-id-type="doi">10.1126/science.1231143</pub-id>
        <?supplied-pmid 23287718?>
        <pub-id pub-id-type="pmid">23287718</pub-id>
      </element-citation>
    </ref>
    <ref id="CR3">
      <label>3.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gilbert</surname>
            <given-names>LA</given-names>
          </name>
          <name>
            <surname>Horlbeck</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Adamson</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Villalta</surname>
            <given-names>JE</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Whitehead</surname>
            <given-names>EH</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Genome-scale CRISPR-mediated control of gene repression and activation</article-title>
        <source>Cell.</source>
        <year>2014</year>
        <volume>159</volume>
        <fpage>647</fpage>
        <lpage>661</lpage>
        <pub-id pub-id-type="doi">10.1016/j.cell.2014.09.029</pub-id>
        <?supplied-pmid 25307932?>
        <pub-id pub-id-type="pmid">25307932</pub-id>
      </element-citation>
    </ref>
    <ref id="CR4">
      <label>4.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Konermann</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Brigham</surname>
            <given-names>MD</given-names>
          </name>
          <name>
            <surname>Trevino</surname>
            <given-names>AE</given-names>
          </name>
          <name>
            <surname>Joung</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Abudayyeh</surname>
            <given-names>OO</given-names>
          </name>
          <name>
            <surname>Barcena</surname>
            <given-names>C</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex</article-title>
        <source>Nature.</source>
        <year>2015</year>
        <volume>517</volume>
        <fpage>583</fpage>
        <lpage>588</lpage>
        <pub-id pub-id-type="doi">10.1038/nature14136</pub-id>
        <?supplied-pmid 25494202?>
        <pub-id pub-id-type="pmid">25494202</pub-id>
      </element-citation>
    </ref>
    <ref id="CR5">
      <label>5.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Komor</surname>
            <given-names>AC</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>YB</given-names>
          </name>
          <name>
            <surname>Packer</surname>
            <given-names>MS</given-names>
          </name>
          <name>
            <surname>Zuris</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>DR</given-names>
          </name>
        </person-group>
        <article-title>Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage</article-title>
        <source>Nature.</source>
        <year>2016</year>
        <volume>533</volume>
        <fpage>420</fpage>
        <lpage>424</lpage>
        <pub-id pub-id-type="doi">10.1038/nature17946</pub-id>
        <?supplied-pmid 27096365?>
        <pub-id pub-id-type="pmid">27096365</pub-id>
      </element-citation>
    </ref>
    <ref id="CR6">
      <label>6.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wells</surname>
            <given-names>JN</given-names>
          </name>
          <name>
            <surname>Feschotte</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <article-title>A field guide to eukaryotic transposable elements</article-title>
        <source>Annu Rev Genet.</source>
        <year>2020</year>
        <volume>54</volume>
        <fpage>539</fpage>
        <lpage>561</lpage>
        <pub-id pub-id-type="doi">10.1146/annurev-genet-040620-022145</pub-id>
        <?supplied-pmid 32955944?>
        <pub-id pub-id-type="pmid">32955944</pub-id>
      </element-citation>
    </ref>
    <ref id="CR7">
      <label>7.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Fueyo</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Judd</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Feschotte</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Wysocka</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Roles of transposable elements in the regulation of mammalian transcription</article-title>
        <source>Nat Rev Mol Cell Biol.</source>
        <year>2022</year>
        <volume>23</volume>
        <fpage>481</fpage>
        <lpage>497</lpage>
        <pub-id pub-id-type="doi">10.1038/s41580-022-00457-y</pub-id>
        <?supplied-pmid 35228718?>
        <pub-id pub-id-type="pmid">35228718</pub-id>
      </element-citation>
    </ref>
    <ref id="CR8">
      <label>8.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Macfarlan</surname>
            <given-names>TS</given-names>
          </name>
          <name>
            <surname>Gifford</surname>
            <given-names>WD</given-names>
          </name>
          <name>
            <surname>Driscoll</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Lettieri</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Rowe</surname>
            <given-names>HM</given-names>
          </name>
          <name>
            <surname>Bonanomi</surname>
            <given-names>D</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Embryonic stem cell potency fluctuates with endogenous retrovirus activity</article-title>
        <source>Nature.</source>
        <year>2012</year>
        <volume>487</volume>
        <fpage>57</fpage>
        <lpage>63</lpage>
        <pub-id pub-id-type="doi">10.1038/nature11244</pub-id>
        <?supplied-pmid 22722858?>
        <pub-id pub-id-type="pmid">22722858</pub-id>
      </element-citation>
    </ref>
    <ref id="CR9">
      <label>9.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Grow</surname>
            <given-names>EJ</given-names>
          </name>
          <name>
            <surname>Flynn</surname>
            <given-names>RA</given-names>
          </name>
          <name>
            <surname>Chavez</surname>
            <given-names>SL</given-names>
          </name>
          <name>
            <surname>Bayless</surname>
            <given-names>NL</given-names>
          </name>
          <name>
            <surname>Wossidlo</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Wesche</surname>
            <given-names>DJ</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Intrinsic retroviral reactivation in human preimplantation embryos and pluripotent cells</article-title>
        <source>Nature.</source>
        <year>2015</year>
        <volume>522</volume>
        <fpage>221</fpage>
        <lpage>225</lpage>
        <pub-id pub-id-type="doi">10.1038/nature14308</pub-id>
        <?supplied-pmid 25896322?>
        <pub-id pub-id-type="pmid">25896322</pub-id>
      </element-citation>
    </ref>
    <ref id="CR10">
      <label>10.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Göke</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Lu</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Chan</surname>
            <given-names>Y-S</given-names>
          </name>
          <name>
            <surname>Ng</surname>
            <given-names>H-H</given-names>
          </name>
          <name>
            <surname>Ly</surname>
            <given-names>L-H</given-names>
          </name>
          <name>
            <surname>Sachs</surname>
            <given-names>F</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Dynamic transcription of distinct classes of endogenous retroviral elements Marks specific populations of early human embryonic cells</article-title>
        <source>Cell Stem Cell.</source>
        <year>2015</year>
        <volume>16</volume>
        <fpage>135</fpage>
        <lpage>141</lpage>
        <pub-id pub-id-type="doi">10.1016/j.stem.2015.01.005</pub-id>
        <?supplied-pmid 25658370?>
        <pub-id pub-id-type="pmid">25658370</pub-id>
      </element-citation>
    </ref>
    <ref id="CR11">
      <label>11.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Pontis</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Planet</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Offner</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Turelli</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Duc</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Coudray</surname>
            <given-names>A</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Hominoid-specific transposable elements and KZFPs facilitate human embryonic genome activation and control transcription in naive human ESCs</article-title>
        <source>Cell Stem Cell.</source>
        <year>2019</year>
        <volume>24</volume>
        <fpage>724</fpage>
        <lpage>735.e5</lpage>
        <pub-id pub-id-type="doi">10.1016/j.stem.2019.03.012</pub-id>
        <?supplied-pmid 31006620?>
        <pub-id pub-id-type="pmid">31006620</pub-id>
      </element-citation>
    </ref>
    <ref id="CR12">
      <label>12.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Xiang</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Tao</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>DiRusso</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Hsu</surname>
            <given-names>F-M</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Xue</surname>
            <given-names>Z</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Human reproduction is regulated by retrotransposons derived from ancient Hominidae-specific viral infections</article-title>
        <source>Nat Commun.</source>
        <year>2022</year>
        <volume>13</volume>
        <fpage>463</fpage>
        <pub-id pub-id-type="doi">10.1038/s41467-022-28105-1</pub-id>
        <?supplied-pmid 35075135?>
        <pub-id pub-id-type="pmid">35075135</pub-id>
      </element-citation>
    </ref>
    <ref id="CR13">
      <label>13.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ai</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Xiang</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Xiang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Szczerbinska</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Qian</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Xu</surname>
            <given-names>X</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Krüppel-like factor 5 rewires NANOG regulatory network to activate human naive pluripotency specific LTR7Ys and promote naive pluripotency</article-title>
        <source>Cell Rep.</source>
        <year>2022</year>
        <volume>40</volume>
        <fpage>111240</fpage>
        <pub-id pub-id-type="doi">10.1016/j.celrep.2022.111240</pub-id>
        <?supplied-pmid 36001968?>
        <pub-id pub-id-type="pmid">36001968</pub-id>
      </element-citation>
    </ref>
    <ref id="CR14">
      <label>14.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chuong</surname>
            <given-names>EB</given-names>
          </name>
          <name>
            <surname>Elde</surname>
            <given-names>NC</given-names>
          </name>
          <name>
            <surname>Feschotte</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <article-title>Regulatory evolution of innate immunity through co-option of endogenous retroviruses</article-title>
        <source>Science.</source>
        <year>2016</year>
        <volume>351</volume>
        <fpage>1083</fpage>
        <lpage>1087</lpage>
        <pub-id pub-id-type="doi">10.1126/science.aad5497</pub-id>
        <?supplied-pmid 26941318?>
        <pub-id pub-id-type="pmid">26941318</pub-id>
      </element-citation>
    </ref>
    <ref id="CR15">
      <label>15.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hummel</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Hansen</surname>
            <given-names>EC</given-names>
          </name>
          <name>
            <surname>Yoveva</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Aprile-Garcia</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Hussong</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Sawarkar</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>The evolutionary capacitor HSP90 buffers the regulatory effects of mammalian endogenous retroviruses</article-title>
        <source>Nat Struct Mol Biol.</source>
        <year>2017</year>
        <volume>24</volume>
        <fpage>234</fpage>
        <lpage>242</lpage>
        <pub-id pub-id-type="doi">10.1038/nsmb.3368</pub-id>
        <?supplied-pmid 28134929?>
        <pub-id pub-id-type="pmid">28134929</pub-id>
      </element-citation>
    </ref>
    <ref id="CR16">
      <label>16.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Preissl</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Amaral</surname>
            <given-names>ML</given-names>
          </name>
          <name>
            <surname>Grinstein</surname>
            <given-names>JD</given-names>
          </name>
          <name>
            <surname>Farah</surname>
            <given-names>EN</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Transcriptionally active HERV-H retrotransposons demarcate topologically associating domains in human pluripotent stem cells</article-title>
        <source>Nat Genet.</source>
        <year>2019</year>
        <volume>51</volume>
        <fpage>1380</fpage>
        <lpage>1388</lpage>
        <pub-id pub-id-type="doi">10.1038/s41588-019-0479-7</pub-id>
        <?supplied-pmid 31427791?>
        <pub-id pub-id-type="pmid">31427791</pub-id>
      </element-citation>
    </ref>
    <ref id="CR17">
      <label>17.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Todd</surname>
            <given-names>CD</given-names>
          </name>
          <name>
            <surname>Deniz</surname>
            <given-names>Ö</given-names>
          </name>
          <name>
            <surname>Taylor</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Branco</surname>
            <given-names>MR</given-names>
          </name>
        </person-group>
        <article-title>Functional evaluation of transposable elements as enhancers in mouse embryonic and trophoblast stem cells</article-title>
        <source>eLife.</source>
        <year>2019</year>
        <volume>8</volume>
        <fpage>e44344</fpage>
        <pub-id pub-id-type="doi">10.7554/eLife.44344</pub-id>
        <?supplied-pmid 31012843?>
        <pub-id pub-id-type="pmid">31012843</pub-id>
      </element-citation>
    </ref>
    <ref id="CR18">
      <label>18.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Karamitros</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Hurst</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Marchi</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Karamichali</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Georgopoulou</surname>
            <given-names>U</given-names>
          </name>
          <name>
            <surname>Mentis</surname>
            <given-names>A</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Human endogenous retrovirus-K HML-2 integration within <italic>RASGRF2</italic> is associated with intravenous drug abuse and modulates transcription in a cell-line model</article-title>
        <source>Proc Natl Acad Sci U S A.</source>
        <year>2018</year>
        <volume>115</volume>
        <fpage>10434</fpage>
        <lpage>10439</lpage>
        <pub-id pub-id-type="doi">10.1073/pnas.1811940115</pub-id>
        <?supplied-pmid 30249655?>
        <pub-id pub-id-type="pmid">30249655</pub-id>
      </element-citation>
    </ref>
    <ref id="CR19">
      <label>19.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Fuentes</surname>
            <given-names>DR</given-names>
          </name>
          <name>
            <surname>Swigut</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Wysocka</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Systematic perturbation of retroviral LTRs reveals widespread long-range effects on human gene regulation</article-title>
        <source>eLife.</source>
        <year>2018</year>
        <volume>7</volume>
        <fpage>e35989</fpage>
        <pub-id pub-id-type="doi">10.7554/eLife.35989</pub-id>
        <?supplied-pmid 30070637?>
        <pub-id pub-id-type="pmid">30070637</pub-id>
      </element-citation>
    </ref>
    <ref id="CR20">
      <label>20.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Padmanabhan Nair</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Ciceri</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Jungverdorben</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Frishman</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Tchieu</surname>
            <given-names>J</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Activation of HERV-K (HML-2) disrupts cortical patterning and neuronal differentiation by increasing NTRK3</article-title>
        <source>Cell Stem Cell.</source>
        <year>2021</year>
        <volume>28</volume>
        <fpage>1566</fpage>
        <lpage>1581.e8</lpage>
        <pub-id pub-id-type="doi">10.1016/j.stem.2021.04.009</pub-id>
        <?supplied-pmid 33951478?>
        <pub-id pub-id-type="pmid">33951478</pub-id>
      </element-citation>
    </ref>
    <ref id="CR21">
      <label>21.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Aho</surname>
            <given-names>AV</given-names>
          </name>
          <name>
            <surname>Corasick</surname>
            <given-names>MJ</given-names>
          </name>
        </person-group>
        <article-title>Efficient string matching: an aid to bibliographic search</article-title>
        <source>Commun ACM.</source>
        <year>1975</year>
        <volume>18</volume>
        <fpage>333</fpage>
        <lpage>340</lpage>
        <pub-id pub-id-type="doi">10.1145/360825.360855</pub-id>
      </element-citation>
    </ref>
    <ref id="CR22">
      <label>22.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Moreno-Mateos</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Vejnar</surname>
            <given-names>CE</given-names>
          </name>
          <name>
            <surname>Beaudoin</surname>
            <given-names>J-D</given-names>
          </name>
          <name>
            <surname>Fernandez</surname>
            <given-names>JP</given-names>
          </name>
          <name>
            <surname>Mis</surname>
            <given-names>EK</given-names>
          </name>
          <name>
            <surname>Khokha</surname>
            <given-names>MK</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>CRISPRscan: designing highly efficient sgRNAs for CRISPR-Cas9 targeting in vivo</article-title>
        <source>Nat Methods.</source>
        <year>2015</year>
        <volume>12</volume>
        <fpage>982</fpage>
        <lpage>988</lpage>
        <pub-id pub-id-type="doi">10.1038/nmeth.3543</pub-id>
        <?supplied-pmid 26322839?>
        <pub-id pub-id-type="pmid">26322839</pub-id>
      </element-citation>
    </ref>
    <ref id="CR23">
      <label>23.</label>
      <mixed-citation publication-type="other">Mendoza BJ, Trinh CT. Enhanced guide-RNA design and targeting analysis for precise CRISPR genome editing of single and consortia of industrially relevant and non-model organisms. Bioinform. 2018;34:16–23.</mixed-citation>
    </ref>
    <ref id="CR24">
      <label>24.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lanciano</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Cristofari</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>Measuring and interpreting transposable element expression</article-title>
        <source>Nat Rev Genet.</source>
        <year>2020</year>
        <volume>21</volume>
        <fpage>721</fpage>
        <lpage>736</lpage>
        <pub-id pub-id-type="doi">10.1038/s41576-020-0251-y</pub-id>
        <?supplied-pmid 32576954?>
        <pub-id pub-id-type="pmid">32576954</pub-id>
      </element-citation>
    </ref>
    <ref id="CR25">
      <label>25.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Cuerda-Gil</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Shahid</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Slotkin</surname>
            <given-names>RK</given-names>
          </name>
        </person-group>
        <article-title>The epigenetic control of the transposable element life cycle in plant genomes and beyond</article-title>
        <source>Annu Rev Genet.</source>
        <year>2022</year>
        <volume>56</volume>
        <fpage>63</fpage>
        <lpage>87</lpage>
        <pub-id pub-id-type="doi">10.1146/annurev-genet-072920-015534</pub-id>
        <?supplied-pmid 36449356?>
        <pub-id pub-id-type="pmid">36449356</pub-id>
      </element-citation>
    </ref>
    <ref id="CR26">
      <label>26.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Pickar-Oliver</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Gersbach</surname>
            <given-names>CA</given-names>
          </name>
        </person-group>
        <article-title>The next generation of CRISPR–Cas technologies and applications</article-title>
        <source>Nat Rev Mol Cell Biol.</source>
        <year>2019</year>
        <volume>20</volume>
        <fpage>490</fpage>
        <lpage>507</lpage>
        <pub-id pub-id-type="doi">10.1038/s41580-019-0131-5</pub-id>
        <?supplied-pmid 31147612?>
        <pub-id pub-id-type="pmid">31147612</pub-id>
      </element-citation>
    </ref>
    <ref id="CR27">
      <label>27.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>McCarty</surname>
            <given-names>NS</given-names>
          </name>
          <name>
            <surname>Graham</surname>
            <given-names>AE</given-names>
          </name>
          <name>
            <surname>Studená</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Ledesma-Amaro</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>Multiplexed CRISPR technologies for gene editing and transcriptional regulation</article-title>
        <source>Nat Commun.</source>
        <year>2020</year>
        <volume>11</volume>
        <fpage>1281</fpage>
        <pub-id pub-id-type="doi">10.1038/s41467-020-15053-x</pub-id>
        <?supplied-pmid 32152313?>
        <pub-id pub-id-type="pmid">32152313</pub-id>
      </element-citation>
    </ref>
    <ref id="CR28">
      <label>28.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>T</given-names>
          </name>
        </person-group>
        <article-title>Computational approaches for effective CRISPR guide RNA design and evaluation</article-title>
        <source>Comput Struct Biotechnol J.</source>
        <year>2020</year>
        <volume>18</volume>
        <fpage>35</fpage>
        <lpage>44</lpage>
        <pub-id pub-id-type="doi">10.1016/j.csbj.2019.11.006</pub-id>
        <?supplied-pmid 31890142?>
        <pub-id pub-id-type="pmid">31890142</pub-id>
      </element-citation>
    </ref>
    <ref id="CR29">
      <label>29.</label>
      <mixed-citation publication-type="other">Abadi S, Yan WX, Amar D, Mayrose I. A machine learning approach for predicting CRISPR-Cas9 cleavage efficiencies and patterns underlying its mechanism of action. PLoS Comput Biol. 2017;13:e1005807.</mixed-citation>
    </ref>
    <ref id="CR30">
      <label>30.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chuai</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Ma</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Yan</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Hong</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Xue</surname>
            <given-names>D</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>DeepCRISPR: optimized CRISPR guide RNA design by deep learning</article-title>
        <source>Genome Biol.</source>
        <year>2018</year>
        <volume>19</volume>
        <fpage>80</fpage>
        <pub-id pub-id-type="doi">10.1186/s13059-018-1459-4</pub-id>
        <?supplied-pmid 29945655?>
        <pub-id pub-id-type="pmid">29945655</pub-id>
      </element-citation>
    </ref>
    <ref id="CR31">
      <label>31.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bostock</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Ogievetsky</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Heer</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>D<sup>3</sup> Data-Driven Documents</article-title>
        <source>IEEE Trans Vis Comput Graph.</source>
        <year>2011</year>
        <volume>17</volume>
        <fpage>2301</fpage>
        <lpage>2309</lpage>
        <pub-id pub-id-type="doi">10.1109/TVCG.2011.185</pub-id>
        <?supplied-pmid 22034350?>
        <pub-id pub-id-type="pmid">22034350</pub-id>
      </element-citation>
    </ref>
  </ref-list>
</back>
<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName A++V2.4.dtd?>
<?SourceDTD.Version 2.4?>
<?ConverterInfo.XSLTName springer2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Mob DNA</journal-id>
    <journal-id journal-id-type="iso-abbrev">Mob DNA</journal-id>
    <journal-title-group>
      <journal-title>Mobile DNA</journal-title>
    </journal-title-group>
    <issn pub-type="epub">1759-8753</issn>
    <publisher>
      <publisher-name>BioMed Central</publisher-name>
      <publisher-loc>London</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">10832116</article-id>
    <article-id pub-id-type="publisher-id">313</article-id>
    <article-id pub-id-type="doi">10.1186/s13100-024-00313-0</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Software</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>CRISPR-TE: a web-based tool to generate single guide RNAs targeting transposable elements</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Guo</surname>
          <given-names>Yixin</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Xue</surname>
          <given-names>Ziwei</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Gong</surname>
          <given-names>Meiting</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Jin</surname>
          <given-names>Siqian</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Wu</surname>
          <given-names>Xindi</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Liu</surname>
          <given-names>Wanlu</given-names>
        </name>
        <address>
          <email>wanluliu@intl.zju.edu.cn</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.13402.34</institution-id><institution-id institution-id-type="ISNI">0000 0004 1759 700X</institution-id><institution>Department of Orthopedic Surgery of the Second Affiliated Hospital, and Centre of Biomedical Systems and Informatics of Zhejiang University-University of Edinburgh Institute (ZJU-UoE Institute), Zhejiang University School of Medicine, </institution><institution>Zhejiang University, </institution></institution-wrap>Zhejiang, Hangzhou 310003 China </aff>
      <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00a2xv884</institution-id><institution-id institution-id-type="GRID">grid.13402.34</institution-id><institution-id institution-id-type="ISNI">0000 0004 1759 700X</institution-id><institution>Future Health Laboratory, Innovation Center of Yangtze River Delta, </institution><institution>Zhejiang University, </institution></institution-wrap>Jiaxing, 314100 China </aff>
    </contrib-group>
    <pub-date pub-type="epub">
      <day>1</day>
      <month>2</month>
      <year>2024</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>1</day>
      <month>2</month>
      <year>2024</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2024</year>
    </pub-date>
    <volume>15</volume>
    <elocation-id>3</elocation-id>
    <history>
      <date date-type="received">
        <day>29</day>
        <month>6</month>
        <year>2023</year>
      </date>
      <date date-type="accepted">
        <day>13</day>
        <month>1</month>
        <year>2024</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2024</copyright-statement>
      <license>
        <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p>
      </license>
    </permissions>
    <abstract id="Abs1">
      <sec>
        <title>Background</title>
        <p id="Par1">The CRISPR/Cas systems have emerged as powerful tools in genome engineering. Recent studies highlighting the crucial role of transposable elements (TEs) have stimulated research interest in manipulating these elements to understand their functions. However, designing single guide RNAs (sgRNAs) that are specific and efficient for TE manipulation is a significant challenge, given their sequence repetitiveness and high copy numbers. While various sgRNA design tools have been developed for gene editing, an optimized sgRNA designer for TE manipulation has yet to be established.</p>
      </sec>
      <sec>
        <title>Results</title>
        <p id="Par2">We present CRISPR-TE, a web-based application featuring an accessible graphical user interface, available at <ext-link ext-link-type="uri" xlink:href="https://www.crisprte.cn/">https://www.crisprte.cn/</ext-link>, and currently tailored to the human and mouse genomes. CRISPR-TE identifies all potential sgRNAs for TEs and provides a comprehensive solution for efficient TE targeting at both the single copy and subfamily levels. Our analysis shows that sgRNAs targeting TEs can more effectively target evolutionarily young TEs with conserved sequences at the subfamily level.</p>
      </sec>
      <sec>
        <title>Conclusions</title>
        <p id="Par3">CRISPR-TE offers a versatile framework for designing sgRNAs for TE targeting. CRISPR-TE is publicly accessible at <ext-link ext-link-type="uri" xlink:href="https://www.crisprte.cn/">https://www.crisprte.cn/</ext-link> as an online web service and the source code of CRISPR-TE is available at <ext-link ext-link-type="uri" xlink:href="https://github.com/WanluLiuLab/CRISPRTE/">https://github.com/WanluLiuLab/CRISPRTE/</ext-link>.</p>
      </sec>
      <sec>
        <title>Supplementary Information</title>
        <p>The online version contains supplementary material available at 10.1186/s13100-024-00313-0.</p>
      </sec>
    </abstract>
    <custom-meta-group>
      <custom-meta>
        <meta-name>issue-copyright-statement</meta-name>
        <meta-value>© BioMed Central Ltd., part of Springer Nature 2024</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="Sec1">
    <title>Introduction</title>
    <p id="Par4">Since the initial discovery of the CRISPR/Cas9 system for genome editing [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>], the development of catalytically inactive Cas9 variants has further facilitated its application in targeted gene expression activation [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>], repression [<xref ref-type="bibr" rid="CR3">3</xref>], and base editing [<xref ref-type="bibr" rid="CR5">5</xref>]. Transposable elements (TEs) are mobile DNA sequences capable of moving within the genome [<xref ref-type="bibr" rid="CR6">6</xref>]. Though once deemed “genomic dark matter”, recent studies have suggested that TEs may act as cis-regulatory elements, contributing to gene regulation by serving as promoters, enhancers, silencers, and boundary elements [<xref ref-type="bibr" rid="CR7">7</xref>]. For instance, in mouse early embryogenesis, the endogenous retrovirus MuERV-L serves as an alternative promoter for certain genes specific to the two-cell stage that are bound and induced by the transcription factor Dux [<xref ref-type="bibr" rid="CR8">8</xref>]. In humans, the evolutionarily young transposable elements such as LTR7Y, LTR7, and LTR5HS harbor binding sites for several key transcription factors and are posited to regulate both human naïve pluripotency and germline lineage commitment [<xref ref-type="bibr" rid="CR9">9</xref>–<xref ref-type="bibr" rid="CR13">13</xref>].</p>
    <p id="Par5">The study of TE functions is challenging due to their high copy numbers and their sequence repetitiveness [<xref ref-type="bibr" rid="CR7">7</xref>]. Consequently, designing sgRNAs that efficiently recruit CRISPR/Cas9 system to TEs is key for functionally probing their biological roles. Researchers have targeted individual TE copies with CRISPR/Cas9 or CRISPR inhibition (CRISPRi) systems to delete, insert, or repress specific copies, thereby studying their biological functions [<xref ref-type="bibr" rid="CR14">14</xref>–<xref ref-type="bibr" rid="CR18">18</xref>]. Moreover, there have been efforts to elucidate the functions of TE subfamilies using CRISPRi or CRISPR activation (CRISPRa), involving the design of sgRNAs that target multiple copies within certain TE subfamilies [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR20">20</xref>]. However, these attempts to manipulate TE expression via CRISPRi or CRISPRa have largely relied on sgRNAs selected using gene-centric tools and on the manual design of sgRNAs targeting consensus sequences of TE copies. Employing similar strategies, we have used CRISPRi/a to silence or activate specific TE subfamilies, assessing their potential enhancer roles in human embryonic stem cells and primordial germ cells [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>]. Nonetheless, the prevailing CRISPR design tools are primarily gene-centric and fail to provide adequate on- or off-target information for TEs, limiting in-depth TE functional studies.</p>
    <p id="Par6">In this study, we introduce CRISPR-TE, a web-based bioinformatics tool specifically for designing CRISPR/Cas sgRNAs targeting transposable elements. Our tool can design sgRNAs to target individual TE copies or combinations of sgRNAs to target TE subfamilies. Moreover, CRISPR-TE provides an interactive web interface with swift query capabilities, enabling convenient access and analysis of detailed sgRNA information for researchers. In summary, CRISPR-TE represents a valuable resource for researchers investigating the role of TEs in the genome, facilitating more comprehensive and precise studies of these repetitive elements.</p>
  </sec>
  <sec id="Sec2">
    <title>Results</title>
    <sec id="Sec3">
      <title>CRISPR-TE workflow</title>
      <p id="Par7">CRISPR-TE first constructs a database of sgRNAs by scanning human and mouse genomes for potential target sites containing the PAM (protospacer adjacent motif) sequence (5′-NGG-3′ for SpCas9 from <italic>S. pyogenes</italic>). Upon input of a genome file, the Aho-Corasick pattern matching algorithm efficiently identifies all N20NGG patterns within the reference genome [<xref ref-type="bibr" rid="CR21">21</xref>] (Fig. <xref rid="Fig1" ref-type="fig">1</xref>A). A retrieval tree (trie) data structure stores all sgRNAs, their genomic locations, and 6 bp downstream and upstream sequences (Fig. <xref rid="Fig1" ref-type="fig">1</xref>B). This data structure enables efficient computation of sequence mismatch neighborhoods. Additional data, including sgRNA on-target activity efficiency [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>], TE-specified off-target scores, TE subfamily, individual TE ID (if any), and overlapping genetic elements such as exons, introns, promoter-TSS, intergenic regions, are calculated and stored in the main database table managed by PostgreSQL. Queries for individual TE ID and their genomic coordinates are also available on the CRISPR-TE website. The sgRNA ID (gid) acts as a foreign key linking the database mismatch table, which contains gid, sgRNA sequence, and mismatch neighborhoods (Fig. <xref rid="Fig1" ref-type="fig">1</xref>C). CRISPR-TE offers two strategies for TE-specific sgRNA design: 1) targeting a single individual TE copy with minimal off-targets or 2) targeting TE subfamilies using optimized sgRNA combinations ranked by a greedy algorithm (Fig. <xref rid="Fig1" ref-type="fig">1</xref>D). These strategies provide researchers with comprehensive options for TE studies, enabling them to select the approach best suited to their experimental goals.<fig id="Fig1"><label>Fig. 1</label><caption><p>CRISPR-TE Workflow for Designing sgRNAs Targeting Transposable Elements. <bold>A</bold> Efficiently searches for all potential sgRNA target sites (N20NGG) using the Aho-Corasick algorithm on the genome FASTA file. <bold>B</bold> Employs a trie data structure to efficiently store sgRNA sequences, facilitating hamming distance mismatch searches. <bold>C</bold> Stores comprehensive sgRNA information for human and mouse genomes in a PostgreSQL database, consisting of two tables: the main table contains sgRNA sequences and coordinates, 6bp upstream and downstream sequences, on/off-target scores, genetic element classes, and the targeted TE (if applicable). <bold>D</bold> CRISPR-TE provides two approaches for sgRNA design targeting TEs: (i) targeting a single copy with minimal off-targets, and (ii) targeting a TE subfamily using optimal sgRNA combinations determined by a greedy algorithm</p></caption><graphic xlink:href="13100_2024_313_Fig1_HTML" id="MO1"/></fig></p>
    </sec>
    <sec id="Sec4">
      <title>Web interface</title>
      <p id="Par8">CRISPR-TE features a user-friendly web interface for designing sgRNAs targeting transposable elements. Users input the design objective (targeting TE single copies or subfamilies), the genome assembly (human or mouse), and the name of the targeted TE subfamily or individual TE ID (Fig. <xref rid="Fig2" ref-type="fig">2</xref>A). The annotation query function on the CRISPR-TE website allows users to search for specific genomic coordinate or individual TE IDs (Fig. <xref rid="Fig2" ref-type="fig">2</xref>B). After submitting the sgRNAs design, CRISPR-TE generates an interactive table displaying sgRNA sequences, coordinates, potential off-target numbers with 0, 1, 2, or 3 mismatches, and on/off-target activity scores (Fig. <xref rid="Fig2" ref-type="fig">2</xref>C). Detailed sgRNA information becomes accessible to users by clicking on each row in the summary table. A color-coded graphical representation of the sgRNA target site help users inspect candidate sgRNAs based on their locations (Fig. <xref rid="Fig2" ref-type="fig">2</xref>D). Summary pie charts depict the proportions of target sites by mismatch number and lists of off-target sgRNAs with their sequences and target sites further aid in the selection of suitable sgRNAs (Fig. <xref rid="Fig2" ref-type="fig">2</xref>D). For designing sgRNAs for TE subfamilies, CRISPR-TE generates combinations intended to maximize coverage of the queried TE subfamily. To balance coverage and computational complexity, CRISPR-TE currently supports designing combinations of three sgRNAs. Pie charts and bar plots visualize the proportion of on-target sites and the number of off-target sites for each sgRNA (Fig. <xref rid="Fig2" ref-type="fig">2</xref>E). Users can download the results in Excel, CSV, and PDF format for further analysis and documentation.<fig id="Fig2"><label>Fig. 2</label><caption><p>Screenshot of The CRISPR-TE Web Tool Interface. <bold>A</bold> The CRISPR-TE homepage, which requires three types of input: (i) Design purpose, (ii) Genome assembly, and (iii) Target TE copy ID or genomic coordinates. <bold>B</bold> Tool is provided for querying individual TE copy IDs and their genomic coordinates. <bold>C</bold> After submitting, CRISPR-TE displays all possible sgRNAs along with detailed information, including sgRNA sequence, coordinates, GC content, mismatches, on-target score, and off-target score. <bold>D</bold> CRISPR-TE enables users to examine the locations of sgRNAs on the genome, alongside other genomic features, by clicking on individual sgRNAs. The pie chart on the left illustrates the proportions of target sites with various mismatch counts. A list of all off-target sgRNA, including their sequences, genomic coordinates, and associated genetic element classes, is shown on the right. <bold>E</bold> The results for sgRNA combinations targeting TE subfamilies are presented. This includes the sgRNA sequences, the number of on-target sites, the on-target percentage for the queried TE subfamily, the sgRNA combination coverage, and off-targets on TEs and other genetic element classes</p></caption><graphic xlink:href="13100_2024_313_Fig2_HTML" id="MO2"/></fig></p>
    </sec>
    <sec id="Sec5">
      <title>TE sgRNA analysis of human and mouse</title>
      <p id="Par9">As TEs integrate into the genome, their sequences diverge due to the accumulation of random mutations and truncations. Evolutionarily young subfamilies, often considered as currently or recently active, possess highly similar sequences across different copies. In contrast, sequences of evolutionarily old subfamilies typically exhibit a greater degree of divergence from their consensus sequences [<xref ref-type="bibr" rid="CR24">24</xref>]. We analyzed the percentage copies covered by three sgRNA combinations for all TE subfamilies. As anticipated, sgRNA combinations designed by CRISPR-TE target evolutionarily young families such as LTR7Y, LTR5HS, SVA-D in humans with higher coverage compared to older families (Fig. <xref rid="Fig3" ref-type="fig">3</xref>A and Fig. S<xref rid="MOESM1" ref-type="media">1</xref>). Specifically, in humans, young TE subfamilies like ERVK and SVA show over 50% coverage with three sgRNAs. Similarly, in mice, B2 and ERVK rank as the top covered TE subfamilies (Fig. <xref rid="Fig3" ref-type="fig">3</xref>B). Furthermore, we discovered that evolutionarily young TEs in human and mouse, such as LTR5HS (coverage ranked at 15 in human TE subfamilies) and RLTR6CMm (coverage ranked at 22 in mouse TE subfamilies), can be targeted with over 70% coverage using CRISPR-TE-designed sgRNA combinations at the subfamily level, despite the possibility that some sgRNAs may also target other TE subfamilies with similar sequences (Fig. <xref rid="Fig3" ref-type="fig">3</xref>C). Conversely, for other relatively older TEs such as L1PA10  (coverage ranked at 223 for human TE subfamilies) and B2Mm2 (coverage ranked at 201 for mouse TE subfamilies), CRISPR-TE-designed sgRNA combinations can target only about 20% of copies, although the majority of the designed sgRNAs accurately target the intended TEs (Fig. <xref rid="Fig3" ref-type="fig">3</xref>C). In conclusion, the effectiveness of sgRNA targeting by CRISPR-TE is strongly correlated with the age of the TE, with younger TEs being more amenable to efficient targeting.<fig id="Fig3"><label>Fig. 3</label><caption><p>Analysis of TE sgRNAs in Human and Mouse. <bold>A</bold> Displays the top 20 TE subfamilies with the highest coverage using the best three sgRNA combinations in human (left panel) and mouse (right panel). <bold>B</bold> Box plots showing the coverage achieved by the best three sgRNA combinations in each TE family for human (left panel) and mouse (right panel). <bold>C</bold>. Examples of sgRNAs designed by CRISPR-TE for targeting LTR5HS (upper left panel), L1PA10 (upper right panel), RLTR6BMm (bottom left panel), and B2Mm2 (bottom right panel) TEs. The bar plots indicate the targeted percentage of copies for the top three TE subfamilies using the best three sgRNA combinations. The pie charts represent the genomic distribution of all targeted sites by the corresponding best three sgRNA combinations</p></caption><graphic xlink:href="13100_2024_313_Fig3_HTML" id="MO3"/></fig></p>
    </sec>
  </sec>
  <sec id="Sec6">
    <title>Discussion</title>
    <p id="Par10">This study introduces CRISPR-TE, a specialized sgRNA design tool tailored for the unique challenges associated with TE targeting in genome editing. Our novel approach for sgRNA design offers a significant advancement over traditional gene-targeting tools, addressing the high copy number and sequence repetitiveness that have long hindered effective TE manipulation. Our results indicate that CRISPR-TE can accurately target TE subfamilies, particularly those that are evolutionarily young and exhibit conserved sequences. The tool’s ability to target these TEs with higher coverage suggests that CRISPR-TE is adept at identifying and leveraging the less divergent sequences within these younger subfamilies. This is a crucial development, as it facilitates the functional analysis of TEs that may play significant roles in gene regulation and genome architecture.</p>
    <p id="Par11">While CRISPR-TE has shown promising results, we recognize certain limitations in its current iteration. At present, CRISPR-TE is tailored only to human and mouse genomes using SpCas9. Given the ubiquitous presence and regulatory significance of TEs in various plant species, including maize, where they play a pivotal role in phenotypic regulation [<xref ref-type="bibr" rid="CR25">25</xref>], future enhancements will aim to broaden the tool’s species compatibility and include additional Cas enzymes like Cas12 or Cas13 orthologues [<xref ref-type="bibr" rid="CR26">26</xref>]. We are committed to extending CRISPR-TE’s functionality to encompass a wider array of species and Cas variants in our subsequent updates.</p>
    <p id="Par12">The current version supports three sgRNA combinations for targeting TE subfamilies, primarily to manage the computational complexity, which grows exponentially with additional sgRNAs. This limitation may restrict the tool’s effectiveness, particularly when addressing evolutionarily older TE subfamilies that require more comprehensive sgRNA coverage. To overcome this, future development will focus on refining our greedy algorithm to allow for an increased number of sgRNA combinations, which could enhance the scope of TE subfamily targeting. However, the experimental delivery of multiple sgRNAs into cellular systems or animal models poses its own set of challenges [<xref ref-type="bibr" rid="CR27">27</xref>], particularly when investigating TE subfamily functions.</p>
    <p id="Par13">Furthermore, the potential for off-target effects is an inherent concern due to the repetitive nature of TE sequences. Although CRISPR-TE includes an on-target and off-target scoring system, these algorithms were originally developed for gene targeting and may not be fully optimized for TEs [<xref ref-type="bibr" rid="CR28">28</xref>]. Advances in the specificity of on-target and off-target predictions for TEs remain a priority for future refinement. The incorporation of machine learning algorithms is anticipated to improve the precision of sgRNA efficacy predictions, thereby mitigating the risk of off-target effects [<xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR30">30</xref>].</p>
    <p id="Par14">In conclusion, CRISPR-TE represents a notable step forward in the field of genome engineering, allowing researchers to explore the possible functions of TEs using genome editing tools. As we further imrpove this tool, we anticipate it to become an essential resource for TE research, providing deeper insights in understanding the repetitive elements in the genome.</p>
  </sec>
  <sec id="Sec7">
    <title>Methods</title>
    <sec id="Sec8">
      <title>sgRNA sequence search, annotation, and storage</title>
      <p id="Par15">We utilized the Aho-Corasick string matching algorithm to screen the genome sequences for all occurrences of the N20NGG pattern on both positive and negative strands. We then saved all potential sgRNA sequences into a modified Trie tree data structure. These sequences were classified based on various genetic elements, such as exons, introns, promoter-TSS, and intergenic regions. The genome assembly and annotation versions used were GRCh38.97 for human (<ext-link ext-link-type="uri" xlink:href="http://www.ensembl.org/Homo_sapiens/">http://www.ensembl.org/Homo_sapiens/</ext-link>) and GRCm38.97 for mouse (<ext-link ext-link-type="uri" xlink:href="https://www.ensembl.org/Mus_musculus/">https://www.ensembl.org/Mus_musculus/</ext-link>). We obtained annotations for transposable element (TE) subfamilies and individual TE IDs from RepeatMasker (<ext-link ext-link-type="uri" xlink:href="https://www.repeatmasker.org/">https://www.repeatmasker.org/</ext-link>). Using Trie tree structure, we performed mismatched string pattern matching to identify N20NGG sequences with fewer than 3 mismatched nucleotides in the genome for each sgRNA. We stored the resulting nucleotide sequences, their genomic coordinates, annotations, and mismatch information in a PostgreSQL (version 14.3) database for efficient indexing and rapid searching.</p>
    </sec>
    <sec id="Sec9">
      <title>sgRNA combination search and off-target score</title>
      <p id="Par16">We proposed a computation time-optimized greedy search algorithm to identify all potential sgRNA combinations that can cover most copies of a TE subfamily while ensuring a minimum number of off-target sites in other genetic elements. We ranked all sgRNAs targeting any copies of each TE subfamily based on their total coverage of copies. The sgRNA combination score was computed as a weighted sum of coverage and off-target events, defined by:</p>
      <p id="Par17">
        <disp-formula id="Equa">
          <alternatives>
            <tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$SCORE\;=\;Coverage-\;\lambda_1\;\times\;W_1\;-\lambda_2\;\times\;\left(\lambda_3\;\times\;W_2\;+\;\lambda_4\;\times\;W_3\;+\;\lambda_5\;\times W_4\;+\;\lambda_6\;\times W_5\right)$$\end{document}</tex-math>
            <mml:math id="M2" display="block">
              <mml:mrow>
                <mml:mi>S</mml:mi>
                <mml:mi>C</mml:mi>
                <mml:mi>O</mml:mi>
                <mml:mi>R</mml:mi>
                <mml:mi>E</mml:mi>
                <mml:mspace width="0.277778em"/>
                <mml:mo>=</mml:mo>
                <mml:mspace width="0.277778em"/>
                <mml:mi>C</mml:mi>
                <mml:mi>o</mml:mi>
                <mml:mi>v</mml:mi>
                <mml:mi>e</mml:mi>
                <mml:mi>r</mml:mi>
                <mml:mi>a</mml:mi>
                <mml:mi>g</mml:mi>
                <mml:mi>e</mml:mi>
                <mml:mo>-</mml:mo>
                <mml:mspace width="0.277778em"/>
                <mml:msub>
                  <mml:mi>λ</mml:mi>
                  <mml:mn>1</mml:mn>
                </mml:msub>
                <mml:mspace width="0.277778em"/>
                <mml:mo>×</mml:mo>
                <mml:mspace width="0.277778em"/>
                <mml:msub>
                  <mml:mi>W</mml:mi>
                  <mml:mn>1</mml:mn>
                </mml:msub>
                <mml:mspace width="0.277778em"/>
                <mml:mo>-</mml:mo>
                <mml:msub>
                  <mml:mi>λ</mml:mi>
                  <mml:mn>2</mml:mn>
                </mml:msub>
                <mml:mspace width="0.277778em"/>
                <mml:mo>×</mml:mo>
                <mml:mspace width="0.277778em"/>
                <mml:mfenced close=")" open="(">
                  <mml:msub>
                    <mml:mi>λ</mml:mi>
                    <mml:mn>3</mml:mn>
                  </mml:msub>
                  <mml:mspace width="0.277778em"/>
                  <mml:mo>×</mml:mo>
                  <mml:mspace width="0.277778em"/>
                  <mml:msub>
                    <mml:mi>W</mml:mi>
                    <mml:mn>2</mml:mn>
                  </mml:msub>
                  <mml:mspace width="0.277778em"/>
                  <mml:mo>+</mml:mo>
                  <mml:mspace width="0.277778em"/>
                  <mml:msub>
                    <mml:mi>λ</mml:mi>
                    <mml:mn>4</mml:mn>
                  </mml:msub>
                  <mml:mspace width="0.277778em"/>
                  <mml:mo>×</mml:mo>
                  <mml:mspace width="0.277778em"/>
                  <mml:msub>
                    <mml:mi>W</mml:mi>
                    <mml:mn>3</mml:mn>
                  </mml:msub>
                  <mml:mspace width="0.277778em"/>
                  <mml:mo>+</mml:mo>
                  <mml:mspace width="0.277778em"/>
                  <mml:msub>
                    <mml:mi>λ</mml:mi>
                    <mml:mn>5</mml:mn>
                  </mml:msub>
                  <mml:mspace width="0.277778em"/>
                  <mml:mo>×</mml:mo>
                  <mml:msub>
                    <mml:mi>W</mml:mi>
                    <mml:mn>4</mml:mn>
                  </mml:msub>
                  <mml:mspace width="0.277778em"/>
                  <mml:mo>+</mml:mo>
                  <mml:mspace width="0.277778em"/>
                  <mml:msub>
                    <mml:mi>λ</mml:mi>
                    <mml:mn>6</mml:mn>
                  </mml:msub>
                  <mml:mspace width="0.277778em"/>
                  <mml:mo>×</mml:mo>
                  <mml:msub>
                    <mml:mi>W</mml:mi>
                    <mml:mn>5</mml:mn>
                  </mml:msub>
                </mml:mfenced>
              </mml:mrow>
            </mml:math>
            <graphic xlink:href="13100_2024_313_Article_Equa.gif" position="anchor"/>
          </alternatives>
        </disp-formula>
      </p>
      <p id="Par18">where coverage is the percentage of TE subfamily copies covered by the current sgRNA combination, <italic>W</italic><sub>1</sub> is the number of off-target TEs, <italic>W</italic><sub>2</sub> is the number of off-targets to promoter-TSS, <italic>W</italic><sub>3</sub> is the number of off-target exons, <italic>W</italic><sub>4</sub> is the number of off-target introns, <italic>W</italic><sub>5</sub> is the number of off-target intergenic regions, with weights λ<sub>1</sub> = 1e-3, λ<sub>2</sub> = 1e-4, λ<sub>3</sub> = 0.4, λ<sub>4</sub> = 0.3, λ<sub>5</sub> = 0.4, λ<sub>6</sub> = 0.3, set as default parameters.</p>
      <p id="Par19">We employed a greedy search strategy that involved selecting the top n sgRNAs with the highest combination scores and subsequently ranking the remaining sgRNAs by the increment of the combination score. We greedily added the most optimal sgRNAs to the current combination at each iteration to obtain the final combination of sgRNAs for targeting copies of a TE subfamily.</p>
    </sec>
    <sec id="Sec10">
      <title>Implementation of the CRISPR-TE web server</title>
      <p id="Par20">We developed a web server that enables users to search for sgRNAs targeting TEs, using an intuitive and user-friendly data browser. The front-end interface of the web server was created with HTML5 and CSS3, and all data visualizations were produced using the D3.js framework [<xref ref-type="bibr" rid="CR31">31</xref>]. The back-end data, containing sgRNA sequences and annotations, was managed by the PostgreSQL database system, facilitating prompt responses to user queries. Python3 (v3.9.12) and Django (v3.2.5) were used for communication between the front-end and back-end. The website is accessible at <ext-link ext-link-type="uri" xlink:href="https://www.crisprte.cn/">https://www.crisprte.cn/</ext-link> without the need for registration or login. The CRISPR-TE website’s functionality was thoroughly tested on Google Chrome and Apple Safari browsers. The site is deployed on an Nginx web server (v1.18.0) running on a Linux Ubuntu (v20.04.5 LTS) cloud server system.</p>
    </sec>
  </sec>
  <sec sec-type="supplementary-material">
    <sec id="Sec11">
      <title>Supplementary Information</title>
      <p>
        <supplementary-material content-type="local-data" id="MOESM1">
          <media xlink:href="13100_2024_313_MOESM1_ESM.pdf">
            <caption>
              <p><bold>Additional file 1: Figure S1.</bold> sgRNA Combinations Targeting TE Subfamilies in Human and Mouse. All TE subfamilies are ranked by the targeted coverage using the best sgRNA combinations for human (left panel) and mouse (right panel).</p>
            </caption>
          </media>
        </supplementary-material>
      </p>
    </sec>
  </sec>
</body>
<back>
  <fn-group>
    <fn>
      <p>
        <bold>Publisher’s Note</bold>
      </p>
      <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
    </fn>
  </fn-group>
  <ack>
    <p>We thank all members from the Liu lab at ZJU-UoE institute for their valuable discussions and suggestions. We thank Zhou Yuxin, Qiu Yanran, and Zhang Yiwei for their preliminary exploration of the study. We would like to thank the technical support provided by the Core Facilities, especially the ZJE server of ZJU-UoE institute.</p>
  </ack>
  <notes notes-type="author-contribution">
    <title>Authors’ contributions</title>
    <p>W.L., Y.G., and Z.X. conceptualized the study and developed the experimental approach. Y.G., Z.X., and W.L. wrote the manuscript. Z.X. and Y.G. created the web application. Z.X., Y.G., S.J., M.G, and X.W. executed the algorithm and conducted the bioinformatics analysis. All authors participated in the critical review and revisions of the manuscript.</p>
  </notes>
  <notes notes-type="funding-information">
    <title>Funding</title>
    <p>This work is supported by National Natural Science Foundation of China 32170551 (to W.L.).</p>
  </notes>
  <notes notes-type="data-availability">
    <title>Availability of data and materials</title>
    <p>The CRISPR-TE web tool is publicly available at <ext-link ext-link-type="uri" xlink:href="https://www.crisprte.cn/">https://www.crisprte.cn/</ext-link>. The source code of CRISPR-TE is accessible at <ext-link ext-link-type="uri" xlink:href="https://github.com/WanluLiuLab/CRISPRTE/">https://github.com/WanluLiuLab/CRISPRTE/</ext-link>.</p>
  </notes>
  <notes>
    <title>Declarations</title>
    <notes id="FPar1">
      <title>Ethics approval and consent to participate</title>
      <p id="Par21">Not applicable.</p>
    </notes>
    <notes id="FPar2">
      <title>Consent for publication</title>
      <p id="Par22">Not applicable.</p>
    </notes>
    <notes id="FPar3" notes-type="COI-statement">
      <title>Competing interests</title>
      <p id="Par23">The authors declare no competing interests.</p>
    </notes>
  </notes>
  <ref-list id="Bib1">
    <title>References</title>
    <ref id="CR1">
      <label>1.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Jinek</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Chylinski</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Fonfara</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Hauer</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Doudna</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Charpentier</surname>
            <given-names>E</given-names>
          </name>
        </person-group>
        <article-title>A programmable dual-RNA–guided DNA endonuclease in adaptive bacterial immunity</article-title>
        <source>Science.</source>
        <year>2012</year>
        <volume>337</volume>
        <fpage>816</fpage>
        <lpage>821</lpage>
        <pub-id pub-id-type="doi">10.1126/science.1225829</pub-id>
        <?supplied-pmid 22745249?>
        <pub-id pub-id-type="pmid">22745249</pub-id>
      </element-citation>
    </ref>
    <ref id="CR2">
      <label>2.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Cong</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Ran</surname>
            <given-names>FA</given-names>
          </name>
          <name>
            <surname>Cox</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Lin</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Barretto</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Habib</surname>
            <given-names>N</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Multiplex genome engineering using CRISPR/Cas systems</article-title>
        <source>Science.</source>
        <year>2013</year>
        <volume>339</volume>
        <fpage>819</fpage>
        <lpage>823</lpage>
        <pub-id pub-id-type="doi">10.1126/science.1231143</pub-id>
        <?supplied-pmid 23287718?>
        <pub-id pub-id-type="pmid">23287718</pub-id>
      </element-citation>
    </ref>
    <ref id="CR3">
      <label>3.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gilbert</surname>
            <given-names>LA</given-names>
          </name>
          <name>
            <surname>Horlbeck</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Adamson</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Villalta</surname>
            <given-names>JE</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Whitehead</surname>
            <given-names>EH</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Genome-scale CRISPR-mediated control of gene repression and activation</article-title>
        <source>Cell.</source>
        <year>2014</year>
        <volume>159</volume>
        <fpage>647</fpage>
        <lpage>661</lpage>
        <pub-id pub-id-type="doi">10.1016/j.cell.2014.09.029</pub-id>
        <?supplied-pmid 25307932?>
        <pub-id pub-id-type="pmid">25307932</pub-id>
      </element-citation>
    </ref>
    <ref id="CR4">
      <label>4.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Konermann</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Brigham</surname>
            <given-names>MD</given-names>
          </name>
          <name>
            <surname>Trevino</surname>
            <given-names>AE</given-names>
          </name>
          <name>
            <surname>Joung</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Abudayyeh</surname>
            <given-names>OO</given-names>
          </name>
          <name>
            <surname>Barcena</surname>
            <given-names>C</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex</article-title>
        <source>Nature.</source>
        <year>2015</year>
        <volume>517</volume>
        <fpage>583</fpage>
        <lpage>588</lpage>
        <pub-id pub-id-type="doi">10.1038/nature14136</pub-id>
        <?supplied-pmid 25494202?>
        <pub-id pub-id-type="pmid">25494202</pub-id>
      </element-citation>
    </ref>
    <ref id="CR5">
      <label>5.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Komor</surname>
            <given-names>AC</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>YB</given-names>
          </name>
          <name>
            <surname>Packer</surname>
            <given-names>MS</given-names>
          </name>
          <name>
            <surname>Zuris</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>DR</given-names>
          </name>
        </person-group>
        <article-title>Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage</article-title>
        <source>Nature.</source>
        <year>2016</year>
        <volume>533</volume>
        <fpage>420</fpage>
        <lpage>424</lpage>
        <pub-id pub-id-type="doi">10.1038/nature17946</pub-id>
        <?supplied-pmid 27096365?>
        <pub-id pub-id-type="pmid">27096365</pub-id>
      </element-citation>
    </ref>
    <ref id="CR6">
      <label>6.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wells</surname>
            <given-names>JN</given-names>
          </name>
          <name>
            <surname>Feschotte</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <article-title>A field guide to eukaryotic transposable elements</article-title>
        <source>Annu Rev Genet.</source>
        <year>2020</year>
        <volume>54</volume>
        <fpage>539</fpage>
        <lpage>561</lpage>
        <pub-id pub-id-type="doi">10.1146/annurev-genet-040620-022145</pub-id>
        <?supplied-pmid 32955944?>
        <pub-id pub-id-type="pmid">32955944</pub-id>
      </element-citation>
    </ref>
    <ref id="CR7">
      <label>7.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Fueyo</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Judd</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Feschotte</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Wysocka</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Roles of transposable elements in the regulation of mammalian transcription</article-title>
        <source>Nat Rev Mol Cell Biol.</source>
        <year>2022</year>
        <volume>23</volume>
        <fpage>481</fpage>
        <lpage>497</lpage>
        <pub-id pub-id-type="doi">10.1038/s41580-022-00457-y</pub-id>
        <?supplied-pmid 35228718?>
        <pub-id pub-id-type="pmid">35228718</pub-id>
      </element-citation>
    </ref>
    <ref id="CR8">
      <label>8.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Macfarlan</surname>
            <given-names>TS</given-names>
          </name>
          <name>
            <surname>Gifford</surname>
            <given-names>WD</given-names>
          </name>
          <name>
            <surname>Driscoll</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Lettieri</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Rowe</surname>
            <given-names>HM</given-names>
          </name>
          <name>
            <surname>Bonanomi</surname>
            <given-names>D</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Embryonic stem cell potency fluctuates with endogenous retrovirus activity</article-title>
        <source>Nature.</source>
        <year>2012</year>
        <volume>487</volume>
        <fpage>57</fpage>
        <lpage>63</lpage>
        <pub-id pub-id-type="doi">10.1038/nature11244</pub-id>
        <?supplied-pmid 22722858?>
        <pub-id pub-id-type="pmid">22722858</pub-id>
      </element-citation>
    </ref>
    <ref id="CR9">
      <label>9.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Grow</surname>
            <given-names>EJ</given-names>
          </name>
          <name>
            <surname>Flynn</surname>
            <given-names>RA</given-names>
          </name>
          <name>
            <surname>Chavez</surname>
            <given-names>SL</given-names>
          </name>
          <name>
            <surname>Bayless</surname>
            <given-names>NL</given-names>
          </name>
          <name>
            <surname>Wossidlo</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Wesche</surname>
            <given-names>DJ</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Intrinsic retroviral reactivation in human preimplantation embryos and pluripotent cells</article-title>
        <source>Nature.</source>
        <year>2015</year>
        <volume>522</volume>
        <fpage>221</fpage>
        <lpage>225</lpage>
        <pub-id pub-id-type="doi">10.1038/nature14308</pub-id>
        <?supplied-pmid 25896322?>
        <pub-id pub-id-type="pmid">25896322</pub-id>
      </element-citation>
    </ref>
    <ref id="CR10">
      <label>10.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Göke</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Lu</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Chan</surname>
            <given-names>Y-S</given-names>
          </name>
          <name>
            <surname>Ng</surname>
            <given-names>H-H</given-names>
          </name>
          <name>
            <surname>Ly</surname>
            <given-names>L-H</given-names>
          </name>
          <name>
            <surname>Sachs</surname>
            <given-names>F</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Dynamic transcription of distinct classes of endogenous retroviral elements Marks specific populations of early human embryonic cells</article-title>
        <source>Cell Stem Cell.</source>
        <year>2015</year>
        <volume>16</volume>
        <fpage>135</fpage>
        <lpage>141</lpage>
        <pub-id pub-id-type="doi">10.1016/j.stem.2015.01.005</pub-id>
        <?supplied-pmid 25658370?>
        <pub-id pub-id-type="pmid">25658370</pub-id>
      </element-citation>
    </ref>
    <ref id="CR11">
      <label>11.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Pontis</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Planet</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Offner</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Turelli</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Duc</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Coudray</surname>
            <given-names>A</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Hominoid-specific transposable elements and KZFPs facilitate human embryonic genome activation and control transcription in naive human ESCs</article-title>
        <source>Cell Stem Cell.</source>
        <year>2019</year>
        <volume>24</volume>
        <fpage>724</fpage>
        <lpage>735.e5</lpage>
        <pub-id pub-id-type="doi">10.1016/j.stem.2019.03.012</pub-id>
        <?supplied-pmid 31006620?>
        <pub-id pub-id-type="pmid">31006620</pub-id>
      </element-citation>
    </ref>
    <ref id="CR12">
      <label>12.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Xiang</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Tao</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>DiRusso</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Hsu</surname>
            <given-names>F-M</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Xue</surname>
            <given-names>Z</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Human reproduction is regulated by retrotransposons derived from ancient Hominidae-specific viral infections</article-title>
        <source>Nat Commun.</source>
        <year>2022</year>
        <volume>13</volume>
        <fpage>463</fpage>
        <pub-id pub-id-type="doi">10.1038/s41467-022-28105-1</pub-id>
        <?supplied-pmid 35075135?>
        <pub-id pub-id-type="pmid">35075135</pub-id>
      </element-citation>
    </ref>
    <ref id="CR13">
      <label>13.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ai</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Xiang</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Xiang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Szczerbinska</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Qian</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Xu</surname>
            <given-names>X</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Krüppel-like factor 5 rewires NANOG regulatory network to activate human naive pluripotency specific LTR7Ys and promote naive pluripotency</article-title>
        <source>Cell Rep.</source>
        <year>2022</year>
        <volume>40</volume>
        <fpage>111240</fpage>
        <pub-id pub-id-type="doi">10.1016/j.celrep.2022.111240</pub-id>
        <?supplied-pmid 36001968?>
        <pub-id pub-id-type="pmid">36001968</pub-id>
      </element-citation>
    </ref>
    <ref id="CR14">
      <label>14.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chuong</surname>
            <given-names>EB</given-names>
          </name>
          <name>
            <surname>Elde</surname>
            <given-names>NC</given-names>
          </name>
          <name>
            <surname>Feschotte</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <article-title>Regulatory evolution of innate immunity through co-option of endogenous retroviruses</article-title>
        <source>Science.</source>
        <year>2016</year>
        <volume>351</volume>
        <fpage>1083</fpage>
        <lpage>1087</lpage>
        <pub-id pub-id-type="doi">10.1126/science.aad5497</pub-id>
        <?supplied-pmid 26941318?>
        <pub-id pub-id-type="pmid">26941318</pub-id>
      </element-citation>
    </ref>
    <ref id="CR15">
      <label>15.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hummel</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Hansen</surname>
            <given-names>EC</given-names>
          </name>
          <name>
            <surname>Yoveva</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Aprile-Garcia</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Hussong</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Sawarkar</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>The evolutionary capacitor HSP90 buffers the regulatory effects of mammalian endogenous retroviruses</article-title>
        <source>Nat Struct Mol Biol.</source>
        <year>2017</year>
        <volume>24</volume>
        <fpage>234</fpage>
        <lpage>242</lpage>
        <pub-id pub-id-type="doi">10.1038/nsmb.3368</pub-id>
        <?supplied-pmid 28134929?>
        <pub-id pub-id-type="pmid">28134929</pub-id>
      </element-citation>
    </ref>
    <ref id="CR16">
      <label>16.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Preissl</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Amaral</surname>
            <given-names>ML</given-names>
          </name>
          <name>
            <surname>Grinstein</surname>
            <given-names>JD</given-names>
          </name>
          <name>
            <surname>Farah</surname>
            <given-names>EN</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Transcriptionally active HERV-H retrotransposons demarcate topologically associating domains in human pluripotent stem cells</article-title>
        <source>Nat Genet.</source>
        <year>2019</year>
        <volume>51</volume>
        <fpage>1380</fpage>
        <lpage>1388</lpage>
        <pub-id pub-id-type="doi">10.1038/s41588-019-0479-7</pub-id>
        <?supplied-pmid 31427791?>
        <pub-id pub-id-type="pmid">31427791</pub-id>
      </element-citation>
    </ref>
    <ref id="CR17">
      <label>17.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Todd</surname>
            <given-names>CD</given-names>
          </name>
          <name>
            <surname>Deniz</surname>
            <given-names>Ö</given-names>
          </name>
          <name>
            <surname>Taylor</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Branco</surname>
            <given-names>MR</given-names>
          </name>
        </person-group>
        <article-title>Functional evaluation of transposable elements as enhancers in mouse embryonic and trophoblast stem cells</article-title>
        <source>eLife.</source>
        <year>2019</year>
        <volume>8</volume>
        <fpage>e44344</fpage>
        <pub-id pub-id-type="doi">10.7554/eLife.44344</pub-id>
        <?supplied-pmid 31012843?>
        <pub-id pub-id-type="pmid">31012843</pub-id>
      </element-citation>
    </ref>
    <ref id="CR18">
      <label>18.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Karamitros</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Hurst</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Marchi</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Karamichali</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Georgopoulou</surname>
            <given-names>U</given-names>
          </name>
          <name>
            <surname>Mentis</surname>
            <given-names>A</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Human endogenous retrovirus-K HML-2 integration within <italic>RASGRF2</italic> is associated with intravenous drug abuse and modulates transcription in a cell-line model</article-title>
        <source>Proc Natl Acad Sci U S A.</source>
        <year>2018</year>
        <volume>115</volume>
        <fpage>10434</fpage>
        <lpage>10439</lpage>
        <pub-id pub-id-type="doi">10.1073/pnas.1811940115</pub-id>
        <?supplied-pmid 30249655?>
        <pub-id pub-id-type="pmid">30249655</pub-id>
      </element-citation>
    </ref>
    <ref id="CR19">
      <label>19.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Fuentes</surname>
            <given-names>DR</given-names>
          </name>
          <name>
            <surname>Swigut</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Wysocka</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Systematic perturbation of retroviral LTRs reveals widespread long-range effects on human gene regulation</article-title>
        <source>eLife.</source>
        <year>2018</year>
        <volume>7</volume>
        <fpage>e35989</fpage>
        <pub-id pub-id-type="doi">10.7554/eLife.35989</pub-id>
        <?supplied-pmid 30070637?>
        <pub-id pub-id-type="pmid">30070637</pub-id>
      </element-citation>
    </ref>
    <ref id="CR20">
      <label>20.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Padmanabhan Nair</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Ciceri</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Jungverdorben</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Frishman</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Tchieu</surname>
            <given-names>J</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Activation of HERV-K (HML-2) disrupts cortical patterning and neuronal differentiation by increasing NTRK3</article-title>
        <source>Cell Stem Cell.</source>
        <year>2021</year>
        <volume>28</volume>
        <fpage>1566</fpage>
        <lpage>1581.e8</lpage>
        <pub-id pub-id-type="doi">10.1016/j.stem.2021.04.009</pub-id>
        <?supplied-pmid 33951478?>
        <pub-id pub-id-type="pmid">33951478</pub-id>
      </element-citation>
    </ref>
    <ref id="CR21">
      <label>21.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Aho</surname>
            <given-names>AV</given-names>
          </name>
          <name>
            <surname>Corasick</surname>
            <given-names>MJ</given-names>
          </name>
        </person-group>
        <article-title>Efficient string matching: an aid to bibliographic search</article-title>
        <source>Commun ACM.</source>
        <year>1975</year>
        <volume>18</volume>
        <fpage>333</fpage>
        <lpage>340</lpage>
        <pub-id pub-id-type="doi">10.1145/360825.360855</pub-id>
      </element-citation>
    </ref>
    <ref id="CR22">
      <label>22.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Moreno-Mateos</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Vejnar</surname>
            <given-names>CE</given-names>
          </name>
          <name>
            <surname>Beaudoin</surname>
            <given-names>J-D</given-names>
          </name>
          <name>
            <surname>Fernandez</surname>
            <given-names>JP</given-names>
          </name>
          <name>
            <surname>Mis</surname>
            <given-names>EK</given-names>
          </name>
          <name>
            <surname>Khokha</surname>
            <given-names>MK</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>CRISPRscan: designing highly efficient sgRNAs for CRISPR-Cas9 targeting in vivo</article-title>
        <source>Nat Methods.</source>
        <year>2015</year>
        <volume>12</volume>
        <fpage>982</fpage>
        <lpage>988</lpage>
        <pub-id pub-id-type="doi">10.1038/nmeth.3543</pub-id>
        <?supplied-pmid 26322839?>
        <pub-id pub-id-type="pmid">26322839</pub-id>
      </element-citation>
    </ref>
    <ref id="CR23">
      <label>23.</label>
      <mixed-citation publication-type="other">Mendoza BJ, Trinh CT. Enhanced guide-RNA design and targeting analysis for precise CRISPR genome editing of single and consortia of industrially relevant and non-model organisms. Bioinform. 2018;34:16–23.</mixed-citation>
    </ref>
    <ref id="CR24">
      <label>24.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lanciano</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Cristofari</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>Measuring and interpreting transposable element expression</article-title>
        <source>Nat Rev Genet.</source>
        <year>2020</year>
        <volume>21</volume>
        <fpage>721</fpage>
        <lpage>736</lpage>
        <pub-id pub-id-type="doi">10.1038/s41576-020-0251-y</pub-id>
        <?supplied-pmid 32576954?>
        <pub-id pub-id-type="pmid">32576954</pub-id>
      </element-citation>
    </ref>
    <ref id="CR25">
      <label>25.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Cuerda-Gil</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Shahid</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Slotkin</surname>
            <given-names>RK</given-names>
          </name>
        </person-group>
        <article-title>The epigenetic control of the transposable element life cycle in plant genomes and beyond</article-title>
        <source>Annu Rev Genet.</source>
        <year>2022</year>
        <volume>56</volume>
        <fpage>63</fpage>
        <lpage>87</lpage>
        <pub-id pub-id-type="doi">10.1146/annurev-genet-072920-015534</pub-id>
        <?supplied-pmid 36449356?>
        <pub-id pub-id-type="pmid">36449356</pub-id>
      </element-citation>
    </ref>
    <ref id="CR26">
      <label>26.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Pickar-Oliver</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Gersbach</surname>
            <given-names>CA</given-names>
          </name>
        </person-group>
        <article-title>The next generation of CRISPR–Cas technologies and applications</article-title>
        <source>Nat Rev Mol Cell Biol.</source>
        <year>2019</year>
        <volume>20</volume>
        <fpage>490</fpage>
        <lpage>507</lpage>
        <pub-id pub-id-type="doi">10.1038/s41580-019-0131-5</pub-id>
        <?supplied-pmid 31147612?>
        <pub-id pub-id-type="pmid">31147612</pub-id>
      </element-citation>
    </ref>
    <ref id="CR27">
      <label>27.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>McCarty</surname>
            <given-names>NS</given-names>
          </name>
          <name>
            <surname>Graham</surname>
            <given-names>AE</given-names>
          </name>
          <name>
            <surname>Studená</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Ledesma-Amaro</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>Multiplexed CRISPR technologies for gene editing and transcriptional regulation</article-title>
        <source>Nat Commun.</source>
        <year>2020</year>
        <volume>11</volume>
        <fpage>1281</fpage>
        <pub-id pub-id-type="doi">10.1038/s41467-020-15053-x</pub-id>
        <?supplied-pmid 32152313?>
        <pub-id pub-id-type="pmid">32152313</pub-id>
      </element-citation>
    </ref>
    <ref id="CR28">
      <label>28.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>T</given-names>
          </name>
        </person-group>
        <article-title>Computational approaches for effective CRISPR guide RNA design and evaluation</article-title>
        <source>Comput Struct Biotechnol J.</source>
        <year>2020</year>
        <volume>18</volume>
        <fpage>35</fpage>
        <lpage>44</lpage>
        <pub-id pub-id-type="doi">10.1016/j.csbj.2019.11.006</pub-id>
        <?supplied-pmid 31890142?>
        <pub-id pub-id-type="pmid">31890142</pub-id>
      </element-citation>
    </ref>
    <ref id="CR29">
      <label>29.</label>
      <mixed-citation publication-type="other">Abadi S, Yan WX, Amar D, Mayrose I. A machine learning approach for predicting CRISPR-Cas9 cleavage efficiencies and patterns underlying its mechanism of action. PLoS Comput Biol. 2017;13:e1005807.</mixed-citation>
    </ref>
    <ref id="CR30">
      <label>30.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chuai</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Ma</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Yan</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Hong</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Xue</surname>
            <given-names>D</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>DeepCRISPR: optimized CRISPR guide RNA design by deep learning</article-title>
        <source>Genome Biol.</source>
        <year>2018</year>
        <volume>19</volume>
        <fpage>80</fpage>
        <pub-id pub-id-type="doi">10.1186/s13059-018-1459-4</pub-id>
        <?supplied-pmid 29945655?>
        <pub-id pub-id-type="pmid">29945655</pub-id>
      </element-citation>
    </ref>
    <ref id="CR31">
      <label>31.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bostock</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Ogievetsky</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Heer</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>D<sup>3</sup> Data-Driven Documents</article-title>
        <source>IEEE Trans Vis Comput Graph.</source>
        <year>2011</year>
        <volume>17</volume>
        <fpage>2301</fpage>
        <lpage>2309</lpage>
        <pub-id pub-id-type="doi">10.1109/TVCG.2011.185</pub-id>
        <?supplied-pmid 22034350?>
        <pub-id pub-id-type="pmid">22034350</pub-id>
      </element-citation>
    </ref>
  </ref-list>
</back>
